The role of microglia in retinal neurodegeneration: Alzheimer’s disease, parkinson, and glaucoma.
Open accessAbstract
Microglia, the immunocompetent cells of the central nervous system (CNS), act as neuropathology sensors and are neuroprotective under physiological conditions. Microglia react to injury and degeneration with immune-phenotypic and morphological changes, proliferation, migration, and inflammatory cytokine production. An uncontrolled microglial response secondary to sustained CNS damage can put neuronal survival at risk due to excessive inflammation. A neuroinflammatory response is considered among the etiological factors of the major aged-related neurodegenerative diseases of the CNS, and microglial cells are key players in these neurodegenerative lesions. The retina is an extension of the brain and therefore the inflammatory response in the brain can occur in the retina. The brain and retina are affected in several neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), and glaucoma. AD is an age-related neurodegeneration of the CNS characterized by neuronal and synaptic loss in the cerebral cortex, resulting in cognitive deficit and dementia. The extracellular deposits of beta-amyloid (Aβ) and intraneuronal accumulations of hyperphosphorylated tau protein (pTau) are the hallmarks of this disease. These deposits are also found in the retina and optic nerve. PD is a neurodegenerative locomotor disorder with the progressive loss of dopaminergic neurons in the substantia nigra. This is accompanied by Lewy body inclusion composed of α-synuclein (α-syn) aggregates. PD also involves retinal dopaminergic cell degeneration. Glaucoma is a multifactorial neurodegenerative disease of the optic nerve, characterized by retinal ganglion cell loss. In this pathology, deposition of Aβ, synuclein, and pTau has also been detected in retina. These neurodegenerative diseases share a common pathogenic mechanism, the neuroinflammation, in which microglia play an important role. Microglial activation has been reported in AD, PD, and glaucoma in relation to protein aggregates and degenerated neurons. The activated microglia can release pro-inflammatory cytokines which can aggravate and propagate neuroinflammation, thereby degenerating neurons and impairing brain as well as retinal function. The aim of the present review is to describe the contribution in retina to microglial-mediated neuroinflammation in AD, PD, and glaucomatous neurodegeneration.
AI snapshot
Written from the paper’s full text.
TL;DR
This review argues that microglial-mediated neuroinflammation is a shared pathogenic mechanism in Alzheimer’s disease, Parkinson’s disease, and glaucoma, and that retinal microglial changes may mirror brain pathology. It proposes that modulating microglial phenotype, rather than simply blocking activation, could be a therapeutic strategy and that retinal imaging may aid early diagnosis and monitoring.
Key findings
- AD, PD, and glaucoma share chronic, age-related neurodegeneration with protein aggregates, glial activation, and neuroinflammation; microglial activation has been reported in all three, including in retina.
- Microglia can adopt neurotoxic M1-like or neuroprotective M2-like phenotypes; the review concludes that shifting M1 toward M2 may be more effective than completely blocking microglial activation.
- In AD models, retinal Aβ plaques appeared in APPswe/PS1ΔE9 mice as early as 2.5 months, preceding brain detection; in PD patients, macular inner retinal layer thinning of 15–20% has been reported.
- In glaucoma, microglial activation is described as one of the first events, preceding RGC loss; minocycline or high-dose irradiation reduced microglial activation and RGC death in experimental models.
Methods
- Narrative review of literature on microglia and retinal neurodegeneration in AD, PD, and glaucoma.
- Synthesizes human postmortem/clinical findings and animal models, including transgenic AD mice, MPTP/rotenone PD models, and experimental/DBA/2J glaucoma models.
- Includes a summary table (Table 1) of retinal changes and a schematic figure (Figure 1) of hypothetical neuroinflammatory events; no systematic search or meta-analysis is described.
Limitations
- The paper states that the role of microglia in glaucoma pathophysiology is poorly understood and that better knowledge is needed.
- The paper notes contradictory evidence: Williams et al. found no evidence of Tau, Aβ, TDP-43, ubiquitin, or α-syn deposits in any part of the eyeball in AD patients.
- Evident from the text: this is a narrative review without stated systematic search, quality appraisal, or primary data, and it relies heavily on animal models and postmortem human tissue.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 212 cited sources checked · 0 supported · 0 flagged
- Premisenone given
In glaucoma, deposition of Aβ, synuclein, and pTau has been detected in retina.
“In this pathology, deposition of Aβ, synuclein, and pTau has also been detected in retina.”
Quote in the paperNot a substantial claim - Premisenone given
Microglial activation has been reported in AD, PD, and glaucoma in relation to protein aggregates and degenerated neurons.
“Microglial activation has been reported in AD, PD, and glaucoma in relation to protein aggregates and degenerated neurons.”
Quote in the paperNot a substantial claim - Premisecitation
There is dendritic atrophy of the lateral geniculate nucleus in glaucoma.
“In addition, there is a dendritic atrophy of the lateral geniculate nucleus, the site to which the RGC axons project (Gupta et al., 2007; Park and Ou, 2013).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Gupta et al., 2007 source
Not checked in the free run.
- cites Park and Ou, 2013
Not checked in the free run.
- Premisereasoning
Microglial cells are key players in neurodegenerative lesions.
“A neuroinflammatory response is considered among the etiological factors of the major aged-related neurodegenerative diseases of the CNS, and microglial cells are key players in these neurodegenerative lesions.”
Quote in the paperSubstantial claim - Interpretationreasoning
An uncontrolled microglial response secondary to sustained CNS damage can put neuronal survival at risk due to excessive inflammation.
“An uncontrolled microglial response secondary to sustained CNS damage can put neuronal survival at risk due to excessive inflammation.”
Quote in the paperSubstantial claim
- Premisecitation
Glaucoma is characterized by death of retinal ganglion cells.
“Glaucoma, a neurodegenerative disease of the optic nerve, is characterized by death of retinal ganglion cells (RGCs) (de Hoz et al., 2016).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites de Hoz et al., 2016 source
Not checked in the free run.
- Premisecitation
AD deposits can induce neuronal death by apoptosis.
“These deposits can induce neuronal death by apoptosis (Garcia-Ospina et al., 2003).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Garcia-Ospina et al., 2003
Not checked in the free run.
- Premisecitation
These glaucoma-related alterations can lead to secondary damage such as excitotoxicity, neurotrophin deprivation, oxidative damage, mitochondrial dysfunction, and eventually retinal ganglion cell death.
“These alterations can lead to secondary damage such as, excitotoxicity, neurotrophin deprivation, oxidative damage, mitochondrial dysfunction, and eventually RGC death (Nickells, 1999; Gallego et al., 2012).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
In neurodegenerative diseases, neuroinflammation constitutes a fundamental process in which microglial cells play a key role.
“In neurodegenerative diseases, neuroinflammation constitutes a fundamental process in which microglial cells play a key role (Glass et al., 2010).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Glass et al., 2010 source
Not checked in the free run.
- Premisecitation
Microglia release extracellular microvesicles (EVs) by exocytosis.
“Recently, it has been reported that microglia release extracellular microvesicles (Evs) by exocytosis.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Signaling mediated by CX3CR1 could regulate microglial behavior in neurodegenerative diseases.
“The signaling mediated by CX3CR1 could regulate microglial behavior in the neurodegenerative diseases.”
Quote in the paperNot a substantial claim - Premisecitation
TLR4 and TLR2 are associated with both neuro-inflammation and clearance of protein aggregates in neurodegenerative disorders.
“Concretely, TLR4 and TLR2 are associated with both neuro-inflammation and clearance of protein aggregates in neurodegenerative disorders (Jack et al., 2005).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Jack et al., 2005 source
Not checked in the free run.
- Premisenone given
M1-like microglia generate a massive inflammatory response releasing IL-1β, IL-12, TNF-α and iNOS.
“This phenotype generates a massive inflammatory response releasing interleukin-1β (IL-1β), IL-12, TNF-α and inducible nitric oxide synthase (iNOS).”
Quote in the paperNot a substantial claim - Interpretationcitation
These common pathogenic mechanisms could act individually or synergistically.
“These mechanisms could act individually or synergistically (Ghiso et al., 2013).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ghiso et al., 2013 source
Not checked in the free run.
- Premisecitation
M2 microglial cells are characterized by thin cellular bodies and ramified processes.
“The M2 microglial cells are characterized by thin cellular bodies and ramified processes (Menzies et al., 2010; Komori et al., 2011; Varnum and Ikezu, 2012; Jones and Bouvier, 2014; Zhou et al., 2014).”
Quote in the paperNot a substantial claim0 of 3 sources checked - Premisecitation
Astrocytes and microglia could play a major role in the neuroinflammation associated with neurodegenerative diseases.
“The astrocytes and microglia could play a major role in the neuroinflammation associated with neurodegenerative diseases (Cherry et al., 2014).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Cherry et al., 2014 source
Not checked in the free run.
- Interpretationcitation
The presence of reactive astrocytes, microglial activation, and release of inflammatory mediators such as cytokines, reactive oxygen species, nitric oxide, and TNF-α could cause a state of chronic inflammation that may exert neurotoxic effects.
“The presence of reactive astrocytes, the microglial activation, and the release of inflammatory mediators such as cytokines, reactive oxygen species (ROS), nitric oxide (NO), and Tumor Necrosis Factor-α (TNF-α) could cause a state of chronic inflammation that may exert neurotoxic effects (Cuenca et al., 2014).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Cuenca et al., 2014 source
Not checked in the free run.
- Premisenone given
The presence of protein aggregates in the CNS is a common feature of most neurodegenerative disorders.
“The presence of protein aggregates in the CNS is a common feature of most neurodegenerative disorders.”
Quote in the paperNot a substantial claim - Premisecitation
Microglial cells express TLR1-TLR9 and their co-receptors, which promote microglial activation.
“Microglial cells express these receptors (TLR1-TLR9) and their co-receptors, which promote microglial activation (Gonzalez et al., 2014).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Gonzalez et al., 2014 source
Not checked in the free run.
- Premisenone given
Microglia have an essential role in the physiology and survival of neurons.
“In addition to the immune functions, microglia have an essential role in the physiology and survival of neurons.”
Quote in the paperSubstantial claim - Premisenone given
EVs can be detected in the plasma and other biological fluids such as the cerebral spinal fluid (CSF).
“They can be detected in the plasma and other biological fluids such as the cerebral spinal fluid (CSF).”
Quote in the paperNot a substantial claim - Premisereasoning
Under pathological conditions, astrocytes and microglia can collaborate to induce an inflammatory response.
“Under pathological conditions, astrocytes and microglia can collaborate to induce an inflammatory response.”
Quote in the paperNot a substantial claim - Premisenone given
Protein aggregates are identified by Toll-like receptors (TLRs), which are danger-signal sensors.
“These aggregates are identified by the Toll-like receptors (TLRs) which are danger-signal sensors.”
Quote in the paperNot a substantial claim - Premisecitation
An astrocyte subtype A1 is abundant in AD and PD and other human neurodegenerative diseases.
“By contrast, a recent report has described an astrocyte subtype A1 that is abundant in AD and PD and other human neurodegenerative diseases.”
Quote in the paperNot a substantial claim - Premisecitation
Brain homeostasis without inflammation depends on eliminating extracellular aggregates and apoptotic debris, this being mediated by the TREM2/DAP12 receptor complex.
“Brain homeostasis without inflammation depends on eliminating extracellular aggregates and apoptotic debris, this being mediated by the TREM2/DAP12 receptor complex (Han et al., 2017).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Han et al., 2017 source
Not checked in the free run.
- Premisenone given
During inflammatory conditions, innate immune cells and adaptive immune cells are recruited by chemoattractants to cross the BBB from the periphery.
“During inflammatory conditions, innate immune cells (DCs, neutrophils, monocytes, and natural killer cells) and adaptive immune cells (activated B cells together with CD4+ and CD8+ T cells) are recruited by chemoattractants to cross the BBB from the periphery.”
Quote in the paperNot a substantial claim - Premisecitation
Soluble Aβ oligomers and Aβ fibrils can react to various receptors expressed by microglia, including CD14, CD36, CD47, α6β1 integrin, class A scavenger receptor, RAGE and TLRs.
“The Soluble Aβ oligomers and Aβ fibrils can react to various receptors expressed by microglia, including CD14, CD36, CD47, α6β1 integrin, class A scavenger receptor, receptor for advanced glycosylation end products (RAGE) and TLRs (Stewart et al., 2010).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Stewart et al., 2010 source
Not checked in the free run.
- Premisecitation
Inflammation is one of the possible causes in the development of AD.
“As mentioned before, inflammation is one of the possible causes in the development of AD (Wyss-Coray, 2006).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Wyss-Coray, 2006 source
Not checked in the free run.
- Premisenone given
TREM receptors are thought to play a central role in immune-system regulation and inflammation.
“In microglial cells, other receptors called the “triggering-receptors-expressed-on-myeloid-cells” (TREM) are thought to play a central role in the immune-system regulation and inflammation.”
Quote in the paperNot a substantial claim - Premisecitation
Evidence has been reported that Aβ protein acts by increasing tau pathology through the formation of tau species capable of producing new aggregates.
“Recently, evidence has been reported that Aβ protein acts by increasing tau pathology through the formation of tau species capable of producing new aggregates (Bennett et al., 2017).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Bennett et al., 2017 source
Not checked in the free run.
- Interpretationcitation
Neuroimaging of TSPO using PET is a good marker of neuroinflammation.
“Thus, it has been proposed that neuroimaging of TSPO using PET is a good marker of neuroinflammation (Cosenza-Nashat et al., 2009; Pasqualetti et al., 2015).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisenone given
The presence of this cellular infiltrate in the CNS can directly or indirectly provoke neuroinflammation by producing pro-inflammatory cytokines/chemokines.
“The presence of this cellular infiltrate in the CNS can directly or indirectly provoke neuroinflammation by producing pro-inflammatory cytokines/chemokines.”
Quote in the paperNot a substantial claim - Premisenone given
Activated microglia and astrocytes overexpress mitochondrial translocator protein (TSPO) within or surrounding senile plaques.
“It has been found that activated microglia and astrocytes overexpress mitochondrial translocator protein (TSPO) within or surrounding senile plaques.”
Quote in the paperSubstantial claim - Premisecitation
The binding of Aβ to CD36 promotes TLR4 and/or TLR6 phosphorylation and activation, resulting in production of inflammatory cytokines and chemokines.
“The binding of Aβ to CD36 (cell surface microglial co-receptor) promotes the TLR4 and/or TLR6 phosphorylation and activation, resulting in the production of inflammatory cytokines and chemokines (Stewart et al., 2010).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Stewart et al., 2010 source
Not checked in the free run.
- Premisecitation
The increase in Aβ deposition induces the activation of astrocytes as well as microglia.
“The increase in Aβ deposition induces the activation of astrocytes as well as microglia (Cagnin et al., 2001).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Cagnin et al., 2001 source
Not checked in the free run.
- Premisecitation
Positron emission tomography (PET) is the most widely used in vivo method for detecting microglial activation.
“Positron emission tomography (PET) is the most widely used in vivo method for detecting microglial activation (Owen and Matthews, 2011; Mirzaei et al., 2016).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Owen and Matthews, 2011
Not checked in the free run.
- cites Mirzaei et al., 2016 source
Not checked in the free run.
- Premisecitation
An alternative pathway has been described for intracellular signaling produced by the binding of Aβ to microglial cells, activating NLRP3 inflammasome.
“Recently, an alternative pathway has been described for intracellular signaling produced by the binding of Aβ to microglial cells, activating NLRP3 inflammasome (Heneka et al., 2013; Sheedy et al., 2013).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Other receptors also participate in cell-debris clearance (Fc receptors, complement receptors, scavenger receptors, P2Y, P2RY6, MAC-2, mannose receptor, and LRP).
“In addition, other receptors also participate in cell-debris clearance (Fc receptors, complement receptors, scavenger receptors (SR), pyrimidinergic receptors P2Y, G-protein coupled,6 (P2RY6), macrophage antigen complex 2 (MAC-2), mannose receptor, and low-density lipoprotein receptor-related protein (LRP) (Fu et al., 2014).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Fu et al., 2014
Not checked in the free run.
- Premisecitation
Immunomodulators including CX3CL1, CD200, CD22, CD47, CD95, and neural cell adhesion molecule sustain the rest state of microglia under normal conditions.
“Immunomodulators, including the CX3CL1, CD200, CD22, CD47, CD95, and neural cell adhesion molecule, sustain the rest state of microglia under normal conditions (Chang et al., 2000; Sheridan and Murphy, 2013).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Chang et al., 2000 source
Not checked in the free run.
- cites Sheridan and Murphy, 2013
Not checked in the free run.
- Premisecitation
The LRRK2 gene can promote clearance of α-syn.
“The clearance of α-syn also can be promoted by the leucine-rich repeat kinase 2 (LRRK2) gene.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Schapansky et al., 2015 source
Not checked in the free run.
- Premisecitation
NF-kB is one of the most important signaling pathways associated with microglial activation in PD.
“One of the most important signaling pathways associated with the microglial activation in PD involves nuclear factor-kappa B (NF-kB) (Zhang et al., 2017).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Zhang et al., 2017 source
Not checked in the free run.
- Premisecitation
Proinflammatory mediators TNF-α, IL-1β, and IFN-γ are found at higher levels in the midbrain of PD patients.
“In addition, proinflammatory mediators such as TNF-α, IL-1β, and IFN-γ have been found at higher levels in the midbrain of PD patients (Wang et al., 2015).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Wang et al., 2015 source
Not checked in the free run.
- Premisecitation
Microglial cells clustered around Aβ deposits have become incapable of removing the amyloid.
“Nonetheless, it seems that microglial cells clustered around Aβ− deposits have become incapable of removing the amyloid (Calsolaro and Edison, 2016).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Calsolaro and Edison, 2016 source
Not checked in the free run.
- Premisecitation
Missense mutations in TREM2 lead to a significant risk of developing AD.
“Missense mutations in TREM2 lead to a significant risk of developing AD (Jonsson et al., 2013; Meyer-Luehmann and Prinz, 2015).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Jonsson et al., 2013 source
Not checked in the free run.
- cites Meyer-Luehmann and Prinz, 2015
Not checked in the free run.
- Interpretationcitation
Altered microglial behavior could induce neuronal degeneration in AD.
“The altered microglial behavior could induce neuronal degeneration in AD (Southam et al., 2016).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Southam et al., 2016 source
Not checked in the free run.
- Interpretationcitation
The sustained exposure to cytokines, chemokines and Aβ could be responsible for the functional impairment of microglial cells located around Aβ deposits.
“The sustained exposure to cytokines, chemokines and Aβ, could be responsible for the functional impairment of microglial cells located around Aβ− deposits (Heneka et al., 2015).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Heneka et al., 2015 source
Not checked in the free run.
- Premisecitation
Pathogenic mutations in LRRK2 influence the ability of microglia to internalize and degrade α-syn, exacerbating α-syn-induced microglial pathology and neuroinflammation.
“Pathogenic mutations in LRRK2 influence the ability of microglia to internalize and degrade α-syn, exacerbating α-syn-induced microglial pathology, and neuroinflammation (Schapansky et al., 2015).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Schapansky et al., 2015 source
Not checked in the free run.
- Premisenone given
Aβ deposits can attract and activate microglia.
“As mentioned above, Aβ deposits can attract and activate microglia.”
Quote in the paperNot a substantial claim - Premisecitation
In AD, mutations in ABCA7 can cause a loss of receptor activity, resulting in reduced microglia phagocytic function.
“In AD, mutations in ABCA7 can cause a loss of receptor activity, resulting in reduced microglia phagocytic function (Southam et al., 2016).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Southam et al., 2016 source
Not checked in the free run.
- Premisecitation
MHC-II expression in microglia can play an important role in innate and adaptive immune responses in PD.
“The MHC-II expression in microglia cells can play an important role in the immune responses (innate and adaptive) in PD (Michelucci et al., 2009; Harms et al., 2013; Gonzalez et al., 2015).”
Quote in the paperNot a substantial claim0 of 3 sources checked - Premisecitation
Overexpression of α-syn can induce MHC-II expression by microglia.
“In vivo and in vitro studies have demonstrated that overexpression of α-syn can induce the MHC-II expression by microglia.”
Quote in the paperNot a substantial claim0 of 3 sources checked - Premisecitation
Microglial senescence can enhance the sensitivity of microglia to inflammatory stimuli; this phenomenon is called "priming."
“Microglial senescence can enhance the sensitivity of microglia to inflammatory stimuli; this phenomenon is called “priming” (Heneka et al., 2015).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Heneka et al., 2015 source
Not checked in the free run.
- Premisecitation
In AD, protein aggregation is caused by declining protein homeostasis (proteostasis).
“In AD, protein aggregation is caused by declining of protein homeostasis (proteostasis) (Mosher and Wyss-Coray, 2014).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Mosher and Wyss-Coray, 2014 source
Not checked in the free run.
- Premisecitation
In AD, the Aβ peptide aggregated extracellularly in neuritic plaques produces an inflammatory environment and a chronic activation of microglial and astroglial cells.
“As mentioned above, in AD the Aβ peptide that is aggregated extracellularly in the neuritic plaques produces an inflammatory environment and a chronic activation of microglial and astroglial cells (D'Andrea, 2005).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites D'Andrea, 2005 source
Not checked in the free run.
- Premisenone given
Mutations in TREM2 can trigger the loss of phagocytic capacity in microglial cells.
“Similarly, mutations in TREM2 can trigger the loss of phagocytic capacity in microglial cells.”
Quote in the paperNot a substantial claim - Premisecitation
In later stages of AD, there is destruction of axons, dendrites, and synapses, in which microglia has a relevant role.
“It has been reported that in the later stages of AD, there is destruction of axons, dendrites, and synapses, in which microglia has a relevant role (Parpura et al., 2012).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Parpura et al., 2012 source
Not checked in the free run.
- Premisecitation
In healthy development of the brain, complement proteins participate in synapse pruning; synapses to be cleared express C3 and binding to CR3 on microglia results in microglial phagocytosis of the synapse.
“In the healthy development of the brain, the proteins of complement participate in synapse pruning. Synapses to be cleared express C3 and binding to CR3 on microglia, resulting in microglial phagocytosis of the synapse (Schafer et al., 2012; Southam et al., 2016).”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
In brain, astrocytes as well as microglia are capable of capturing Aβ for degradation.
“In brain, astrocytes as well as microglia are capable of capturing Aβ for degradation (Pihlaja et al., 2011).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Pihlaja et al., 2011 source
Not checked in the free run.
- Premisecitation
Activation of NF-kB can increase the release of proinflammatory cytokines TNF-α and IL-1β by microglial cells.
“The activation of this factor could increase the release of proinflammatory cytokines such TNF-α and interleukin 1β by microglial cells (Mogi et al., 1996; McLaughlin et al., 2006).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Interpretationreasoning
There is a correlation between retinal and brain pathology in AD.
“This situation points out a correlation between retinal and brain pathology in AD.”
Quote in the paperSubstantial claim - Premisecitation
Williams et al. found no evidence of deposits or accumulations of Tau, Aβ, TDP-43, ubiquitin or α-syn in any part of the eyeball in AD patients.
“However, recently Williams et al. in AD patients found no evidence of deposits or accumulations of Tau, Aβ, TDP-43, ubiquitin or α-syn in any part of the eyeball (Williams E. A. et al., 2017).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Williams E. A. et al., 2017
Not checked in the free run.
- Premisecitation
Aβ plaques have been detected in the retina of transgenic mouse models of AD.
“Aβ plaques have also been detected in the retina of transgenic mouse models of AD (APPswe / PS1ΔE9, Tg2576AD, 3xTg-AD, PSAPP, 5xFAD; Hsiao et al., 1996; Holcomb et al., 1998; Takeuchi et al., 2000; Lukiw et al., 2001; Oddo et al., 2003; Kumar-Singh et al., 2005; Oakley et al., 2006; Philipson et al., 2010; Koronyo-Hamaoui et al., 2011).”
Quote in the paperSubstantial claim0 of 3 sources checked - Interpretationreasoning
Detection of retinal Aβ might potentially provide an alternative noninvasive approach to assess progression of AD.
“The detection of retinal Aβ might potentially provide an alternative noninvasive approach to assess the progression of AD.”
Quote in the paperSubstantial claim - Premisecitation
The kynurenic pathway is implicated in inflammatory and neurotoxic processes in PD.
“Recently, the kinurenic pathway (KP) has been implicated in the inflammatory and neurotoxic processes in PD.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Lim C. K. et al., 2017 source
Not checked in the free run.
- Premisecitation
Low astroglial response in PD may be caused by degeneration due to increased α-syn in astrocytes.
“The low astroglial response may be caused by degeneration due to an increase of α-syn in the astrocyte (Stefanova et al., 2001; Orr et al., 2002; Sofroniew and Vinters, 2010).”
Quote in the paperNot a substantial claim0 of 3 sources checked - Premisecitation
Aβ plaques are present in the retina of AD patients and AD human postmortem specimens.
“In addition, in the retina of AD patients as well as AD human postmortem specimens the presence of Aβ plaques has been demonstrated.”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
In AD patients, alloform Aβ42 is increased.
“In AD patients, the alloform Aβ42 is increased (Alexandrov et al., 2011).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Alexandrov et al., 2011 source
Not checked in the free run.
- Premisecitation
Production of NO and superoxide by activated microglia in PD can cause degeneration of dopaminergic neurons.
“The production of NO and superoxide exerted by activated microglia in PD can cause the degeneration of dopaminergic neurons (Appel et al., 2010).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Appel et al., 2010 source
Not checked in the free run.
- Interpretationcitation
Antioxidant capacity in PD CNS tissue could be impaired, probably secondary to astroglial defect.
“A lower level of glutathione has been detected in the CNS of PD patients, and thus the antioxidant capacity in the tissue could be impaired, probably secondary to the astroglial defect (Olanow and Tatton, 1999).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Olanow and Tatton, 1999
Not checked in the free run.
- Premisecitation
Patients with AD often develop visual anomalies correlated with abnormalities in the eye.
“However, in the last few decades it has been demonstrated that patients with AD often develop visual anomalies, which are correlated with abnormalities in the eye.”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
Systemic administration of curcumin to AD mice resulted in specific in vivo labeling of retinal Aβ plaques.
“In relation to this last point, it has been demonstrated that the systemic administration of curcumin to AD mice resulted in specific in vivo labeling of retinal Aβ plaques.”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
Lower levels of glutathione are detected in the CNS of PD patients.
“A lower level of glutathione has been detected in the CNS of PD patients”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Olanow and Tatton, 1999
Not checked in the free run.
- Premisecitation
Neuromelanin can activate microglial cells, inducing neuroinflammation and neurodegeneration of dopaminergic neurons in PD.
“In addition, the neuromelanin (dark, complex endogenous polymer derived from DA) can activate microglial cells, inducing neuroinflammation and neurodegeneration of dopaminergic neurons in PD (Zecca et al., 2008; Herrera et al., 2015).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
In AD retinas, in addition to RGC loss, melanopsin retinal ganglion cells (mRGC) are lost.
“Postmortem studies in AD retinas, have demonstrated that, in addition to RGC loss, melanopsin retinal ganglion cells (mRGC) are lost.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites La Morgia et al., 2011 source
Not checked in the free run.
- Interpretationcitation
Aβ42 peptide accumulation in the retina may contribute to retinal degeneration and visual impairment in AD.
“Aβ42 peptide accumulation in the retina may contribute to retinal degeneration and visual impairment in AD (Hardy and Selkoe, 2002; Selkoe, 2004, 2008; Alexandrov et al., 2011; Ratnayaka et al., 2015; Hart et al., 2016; Figure 1A, Table 1).”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
In APPswe/PS1ΔE9 transgenic mice, Aβ plaques appear in retina at presymptomatic stages as early as 2.5 months, preceding detection in brain.
“In APPswe / PS1ΔE9 transgenic mice, Aβ plaques appeared in the retina of young transgenic AD mice at presymptomatic stages, as early as 2.5 months, preceding their detection in the brain.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Koronyo-Hamaoui et al., 2011 source
Not checked in the free run.
- Premisecitation
pKr-2 induced DA neuronal death in an experimental PD model.
“Also, pKr-2 induced DA neuronal death in an experimental PD model (Kim et al., 2010).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Kim et al., 2010 source
Not checked in the free run.
- Premisecitation
In these AD mouse models, Aβ plaques are found principally in NFL, GCL, IPL, INL, and OPL.
“Overall, in these mice, Aβ plaques were found principally in the NFL, ganglion cell layer (GCL), inner plexiform layer (IPL), inner nuclear layer (INL) and outer plexiform layer (OPL) (Table 1).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Table 1
Not checked in the free run.
- Interpretationcitation
Activated microglia could trigger a neuroinflammatory response contributing to disorganization of retina, as demonstrated by electroretinogram functional alterations.
“In addition, activated microglia could trigger a neuroinflammatory response, which may contribute to a disorganization of the retina, as demonstrated by electroretinogram functional alterations (Krasodomska et al., 2010; Table 1).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Krasodomska et al., 2010 source
Not checked in the free run.
- Interpretationreasoning
AD, PD, and glaucoma share neuroinflammatory changes in the retinal tissue.
“Thus AD, PD, and glaucoma share neuroinflammatory changes in the retinal tissue.”
Quote in the paperSubstantial claim - Premisecitation
In TgF344-AD transgenic rat model, Aβ deposition, microglial recruitment, and complement activation are associated with decline in visual function.
“In the transgenic rat model (TgF344-AD) also has been observed, along with Aβ deposition, microglial recruitment, and complement activation in association with a decline in visual function (Tsai et al., 2014; Table 1).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Tsai et al., 2014 source
Not checked in the free run.
- Interpretationcitation
Aβ played a major role in inflammation and neurodegeneration in AD.
“Thus, the authors suggested that Aβ played a major role in the inflammation and neurodegeneration in AD.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ning et al., 2008 source
Not checked in the free run.
- Premisecitation
High levels of α-syn are found in midbrain dopaminergic neurons in PD.
“In this disease, high levels of α-syn are found in midbrain dopaminergic neurons (Neystat et al., 1999; Solano et al., 2000; Braak et al., 2003; Kingsbury et al., 2004; Alafuzoff and Parkkinen, 2014).”
Quote in the paperNot a substantial claim0 of 3 sources checked - Premisecitation
In postmortem PD eyes, α-syn aggregates are observed inside neurons of different retinal layers, including border of INL, IPL, and GCL.
“In postmortem PD eyes, α-syn aggregates have been observed inside the neurons of different retinal layers, including the border of the INL, the IPL, and the GCL.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Bodis-Wollner et al., 2014 source
Not checked in the free run.
- Interpretationreasoning
Differential activation of microglia (M1 or M2 phenotypes) could constitute a key in neuroinflammation regulation.
“The differential activation of microglia (M1 or M2 phenotypes) can produce a neurotoxic or neuroprotective environment, and could constitute a key in neuroinflammation regulation.”
Quote in the paperSubstantial claim - Interpretationreasoning
Neuroinflammatory processes occur not only in the brain but also in the retina.
“Neuroinflammatory processes occur not only in the brain but also in the retina, because the retina is a projection of the CNS.”
Quote in the paperSubstantial claim- Rests on an assumption: The retina is a projection of the CNS.
- Premisecitation
Deficits in expression of complement factor H (CFH) are associated with significant increases of Aβ42 peptides in brains and retinas of transgenic AD models.
“Deficits have been found in the expression of the innate immune-repressor complement factor H (CFH) associated with significant increases of Aβ42 peptides in brains and retinas of transgenic models of AD (Veerhuis, 2011).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Veerhuis, 2011 source
Not checked in the free run.
- Interpretationcitation
Tau may alter axonal transport.
“These observations suggest that tau may alter axonal transport.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Gasparini et al., 2011 source
Not checked in the free run.
- Interpretationnone given
AD, PD, and glaucoma share a common pathogenic mechanism in which neuroinflammation, in the form of microglial activation, plays an important part.
“AD, PD, and glaucoma are neurodegenerative diseases that share a common pathogenic mechanism, in which the neuroinflammation, in the form of microglial activation, plays an important part.”
Quote in the paperNot a substantial claim - Premisecitation
Significant upregulation of inflammation (astroglial and microglial activation) is found in retinas of AD mouse models in relation to Aβ plaques.
“A significant upregulation of inflammation (evidenced by astroglial and microglial activation) has been found in the retinas of AD mouse models in relation to Aβ plaques (Parnell et al., 2012).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Parnell et al., 2012 source
Not checked in the free run.
- Premisecitation
The serum of glaucoma patients contains high levels of antibodies, including against HSPs.
“The serum of glaucoma patients has been found to contain high levels of antibodies (e.g., against HSPs; Maruyama et al., 2000; Wax et al., 2001; Tezel et al., 2004; Grus et al., 2008).”
Quote in the paperNot a substantial claim0 of 3 sources checked - Interpretationreasoning
The immune response could be involved in the pathogenesis of glaucoma.
“In view of the evidence mentioned above, the immune response could be involved in the pathogenesis of the glaucoma.”
Quote in the paperSubstantial claim - Premisecitation
Axonal degeneration precedes neuronal loss in mouse models of tauopathy and glaucoma.
“This alteration is an early event in tau-induced neuronal dysfunction and corroborates previous findings in mouse models of tautopathy and glaucoma, showing that axonal degeneration precedes neuronal loss (Schlamp et al., 2006; Leroy et al., 2007; Figure 1A, Table 1).”
Quote in the paperNot a substantial claim0 of 2 sources checked
- Classified as probably not a substantial claim. 48
- May combine two claims. 94
Classified as probably not a substantial claim.
Premisenone givenThe brain and retina are affected in several neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and glaucoma.
“The brain and retina are affected in several neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), and glaucoma.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationAD, PD, and glaucoma have similar mechanisms of cell injury and deposition of protein aggregates in specific anatomical areas.
“they have similar mechanisms of cell injury and deposition of protein aggregates in specific anatomical areas (Wostyn et al., 2010; Kaarniranta et al., 2011; Ghiso et al., 2013)”
Quote in the paperSubstantial claim0 of 3 sources checkedMay combine two claims.
InterpretationreasoningAD, PD, and glaucoma share a common pathogenic mechanism, neuroinflammation, in which microglia play an important role.
“These neurodegenerative diseases share a common pathogenic mechanism, the neuroinflammation, in which microglia play an important role.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationAD is frequently associated with vascular dysfunctions and inflammation.
“In addition, AD is frequently associated with vascular dysfunctions and inflammation (Dudvarski Stankovic et al., 2016).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Dudvarski Stankovic et al., 2016 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenLoss of neurons in PD is accompanied by abnormal intracytoplasmic filamentous aggregates called Lewy bodies.
“The loss of neurons is accompanied by abnormal intracytoplasmic filamentous aggregates called Lewy bodies.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationLewy bodies are constituted by α-syn, parkin, phosphorylated neurofilament and components of the protheosomic-ubiquitin pathway.
“These aggregates (deposited in somas and axons) are constituted by α-syn, parkin, phosphorylated neurofilament and components of the protheosomic-ubiquitin pathway (Orr et al., 2002).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Orr et al., 2002 source
Not checked in the free run.
May combine two claims.
PremisecitationAD, PD, and glaucoma are slow and chronic neurodegenerative disorders with a strong age-related incidence.
“they are slow and chronic neurodegenerative disorders with a strong age-related incidence”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based). May combine two claims.
Premisenone givenMicroglia are immunocompetent cells of the central nervous system that act as neuropathology sensors and are neuroprotective under physiological conditions.
“Microglia, the immunocompetent cells of the central nervous system (CNS), act as neuropathology sensors and are neuroprotective under physiological conditions.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe major pathology related to AD is extracellular deposit of Aβ in the form of parenchymal plaques and cerebral amyloid angiopathy co-existing with intraneuronal accumulations of hyperphosphorylated tau (neurofibrillary tangles).
“The major pathology related to AD is the extracellular deposit of β-amyloid (Aβ) in the form of parenchymal plaques and cerebral amyloid angiopathy co-existing with intraneuronal accumulations of hyperphosphorylated tau (pTau) (neurofribillary tangles) (Ghiso et al., 2013).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ghiso et al., 2013 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationAD has been related to genetic mutations, including in the gene encoding the Aβ precursor protein peptide, mutations in presenilins genes, and presence of the APOE ε4 allele.
“AD has been related to genetic mutations, among them in the gene encoding the Aβ precursor protein peptide, mutations in the presenilins genes (Calabrese et al., 2001) and the presence of the APOE ε4 allele (Martínez-Lazcano et al., 2010).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Calabrese et al., 2001 source
Not checked in the free run.
- cites Martínez-Lazcano et al., 2010
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationGenetic factors for PD include mutations in α-syn, while mitochondrial dysfunction and oxidative stress may also act by causing the accumulation of misfolded proteins.
“Genetic factors include mutations in α-syn (Olanow and Tatton, 1999; Pérez and Arancibia, 2007), while mitochondrial dysfunction and oxidative stress may also act by causing the accumulation of misfolded proteins (Dauer and Przedborski, 2003).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Olanow and Tatton, 1999
Not checked in the free run.
- cites Pérez and Arancibia, 2007
Not checked in the free run.
- cites Dauer and Przedborski, 2003 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationNeurodegeneration in PD could be due to exposure to dopaminergic neurotoxins such as herbicides (MPTP), insecticides (Rotenone), and metals.
“Neurodegeneration could be due to exposure to dopaminergic neurotoxins e.g., herbicides (MPTP), insecticides (Rotenone), and metals (Hernández-Montiel, 2006).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hernández-Montiel, 2006
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationPD clinical symptoms are mainly motor problems, including bradykinesia, rigidity, tremors, and postural instability; PD also presents non-motor symptoms including disorganized speech and altered moods.
“The clinical symptoms of PD are mainly motor problems, including bradykinesia, rigidity, tremors, and postural instability. In addition, PD presents non-motor symptoms including disorganized speech and altered moods (Fakhoury, 2016).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Fakhoury, 2016 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Premisenone givenAD is an age-related neurodegeneration of the CNS characterized by neuronal and synaptic loss in the cerebral cortex, resulting in cognitive deficit and dementia.
“AD is an age-related neurodegeneration of the CNS characterized by neuronal and synaptic loss in the cerebral cortex, resulting in cognitive deficit and dementia.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationcitationNeurodegenerative lesions have been detected in the intracranial optic nerve, lateral geniculate nucleus, and visual cortex in glaucoma, suggesting that glaucoma could be grouped as a neurodegenerative disease.
“Recently, neurodegenerative lesions have been detected in the intracranial optic nerve, the lateral geniculate nucleus, and the visual cortex (Gupta et al., 2006, 2007), suggesting that this pathology could be grouped as a neurodegenerative disease (Yucel et al., 2003).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Gupta et al., 2006, 2007
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites Yucel et al., 2003 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenThe main etiological factors proposed for PD are aging, environmental toxins, and genetic factors.
“The main etiological factors proposed for PD are aging, environmental toxins, and genetic factors.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationAD involves progressive memory loss and dementia.
“AD involves progressive memory loss and dementia (Sharma and Lipincott, 2017)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Sharma and Lipincott, 2017
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Premisenone givenPD is a neurodegenerative locomotor disorder with progressive loss of dopaminergic neurons in the substantia nigra.
“PD is a neurodegenerative locomotor disorder with the progressive loss of dopaminergic neurons in the substantia nigra.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Premisenone givenGlaucoma is a multifactorial neurodegenerative disease of the optic nerve, characterized by retinal ganglion cell loss.
“Glaucoma is a multifactorial neurodegenerative disease of the optic nerve, characterized by retinal ganglion cell loss.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningActivated microglia can release pro-inflammatory cytokines which can aggravate and propagate neuroinflammation, thereby degenerating neurons and impairing brain as well as retinal function.
“The activated microglia can release pro-inflammatory cytokines which can aggravate and propagate neuroinflammation, thereby degenerating neurons and impairing brain as well as retinal function.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationPD is a chronic and progressive movement disorder.
“while the PD is a chronic and progressive movement disorder (Orr et al., 2002).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Orr et al., 2002 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Premisenone givenExtracellular deposits of beta-amyloid and intraneuronal accumulations of hyperphosphorylated tau protein are the hallmarks of AD.
“The extracellular deposits of beta-amyloid (Aβ) and intraneuronal accumulations of hyperphosphorylated tau protein (pTau) are the hallmarks of this disease.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAD and PD are the most common neurodegenerative disorders.
“Alzheimer's Disease (AD) and Parkinson's Disease (PD) are the most common neurodegenerative disorders (de Lau and Breteler, 2006).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites de Lau and Breteler, 2006 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationGlaucoma is an age-related multifactorial neurodegenerative disease of the optic nerve, with an irreversible decrease in retinal ganglion cells, causing visual-field loss and cupping of the optic nerve head.
“Glaucoma is an age-related multifactorial neurodegenerative disease of the optic nerve, with an irreversible decrease in RGCs, causing a visual-field loss and cupping of the optic nerve head (Quigley et al., 1988).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Quigley et al., 1988 source
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based).
Premisenone givenA neuroinflammatory response is considered among the etiological factors of the major aged-related neurodegenerative diseases of the CNS.
“A neuroinflammatory response is considered among the etiological factors of the major aged-related neurodegenerative diseases of the CNS, and microglial cells are key players in these neurodegenerative lesions.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenPD is accompanied by Lewy body inclusion composed of α-synuclein aggregates.
“This is accompanied by Lewy body inclusion composed of α-synuclein (α-syn) aggregates.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationAD has a multifactorial origin and seems to result from a complex interaction of multiple environmental and genetic factors.
“However, it is now known to have a multifactorial origin and it seems to result from a complex interaction of multiple environmental and genetic factors (Wostyn et al., 2010).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Wostyn et al., 2010 source
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based).
Premisenone givenAβ and pTau deposits are also found in the retina and optic nerve.
“These deposits are also found in the retina and optic nerve.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisenone givenIn glaucoma, increased intraocular pressure, vascular dysregulation, and immune system activation can trigger changes in retina and optic nerve including disrupted axonal transport and neurofilament accumulation, microvascular abnormalities, extracellular matrix remodeling, and glial cell activation.
“In glaucoma, increased intraocular pressure (IOP), vascular dysregulation, and the immune system activation can trigger several changes in retina and optic nerve including: disrupted axonal transport and neurofilament accumulation, microvascular abnormalities, extracellular matrix remodeling, and glial cell activation.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based). May combine two claims.
Premisenone givenMicroglia react to injury and degeneration with immune-phenotypic and morphological changes, proliferation, migration, and inflammatory cytokine production.
“Microglia react to injury and degeneration with immune-phenotypic and morphological changes, proliferation, migration, and inflammatory cytokine production.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationPD is characterized by progressive loss of dopaminergic neurons in the substantia nigra pars compacta and nerve terminals in the striatum.
“PD is characterized by the progressive loss of dopaminergic neurons in the substantia nigra pars compacta and the nerve terminals in the striatum (Dauer and Przedborski, 2003).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Dauer and Przedborski, 2003 source
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based).
Premisenone givenPD involves retinal dopaminergic cell degeneration.
“PD also involves retinal dopaminergic cell degeneration.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningExcessive microglia activation might prompt the release of cytotoxic factors, causing neuronal damage, which could accelerate the progression of some CNS diseases.
“Excessive microglia activation might prompt the release of cytotoxic factors, causing neuronal damage, which could accelerate the progression of some CNS diseases.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationM2-like microglia secrete anti-inflammatory mediators and neurotrophic factors, thus inducing a supportive microenvironment for neurons.
“The second microglial phenotype, M2-like, secrete anti-inflammatory mediators and neurotrophic factors, thus inducing a supportive microenvironment for neurons (Kettenmann et al., 2011).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Kettenmann et al., 2011 source
Not checked in the free run.
May combine two claims.
InterpretationcitationChanges in OCT measurements have been used to study the course of AD, PD, and glaucoma, suggesting that the data compiled may be useful as a biomarker in diagnosing and treating neurodegenerative disease.
“Changes in OCT measurements have been used to study the course of particular neurologic diseases such AD (Garcia-Martin et al., 2014; Maldonado et al., 2015; Salobrar-Garcia et al., 2015, 2016a,b), PD (Yu et al., 2014; Stemplewitz et al., 2015; Boeke et al., 2016; Satue et al., 2017), and glaucoma (Leung, 2016; Fallon et al., 2017), suggesting that the data compiled may be useful as a biomarker in”
Quote in the paperSubstantial claim0 of 3 sources checkedMay combine two claims.
PremisecitationFractalkine expressed by neurons can induce adenosine release from microglia; this adenosine via adenosine A1 receptor can activate survival pathways in neurons sensitive to excitotoxicity challenge.
“The fractalkine expressed by neurons can induce adenosine release from microglia. This adenosine (via adenosine A1 receptor) can activate survival pathways in neurons sensitive to excitotoxicity challenge (Lauro et al., 2008, 2010).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Lauro et al., 2008, 2010
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenMicroglia constitute the first line of immune defense in the CNS.
“Microglia constitute the first line of immune defense in CNS.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationThe retina is a "window to the brain," and the manifestation of disease in the brain is the same as in the retina.
“Thus, it has been described that the retina is a “window to the brain,” and the manifestation of disease in the brain is the same as in the retina (MacCormick et al., 2015).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites MacCormick et al., 2015 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThese microvesicles are involved in all immune activities and can be protective or detrimental, affecting some pathologies of the CNS.
“These microvesicles are involved in all immune activities and can be protective or detrimental, affecting some pathologies of the CNS.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIn certain circumstances, neuroinflammation can help stimulate myelin repair or remove toxic aggregated proteins and cell debris from the CNS.
“However, in certain circumstances, the neuroinflammation can help stimulate myelin repair or remove toxic aggregated proteins and cell debris from CNS (Ding et al., 2004; Simard et al., 2006; Glezer et al., 2007).”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
InterpretationreasoningAlthough the exact mechanism bringing about neuronal death remains unknown, these neurodegenerative disorders seem to have pathogenic mechanisms in common.
“Although the exact mechanism bringing about this neuronal death remains unknown, these neurodegenerative disorders seem to have pathogenic mechanisms in common.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationMicroglia survey the CNS to detect homeostasis alteration and respond accordingly, combining a defensive service with neuroprotective functions.
“These cells survey the CNS in order to detect homeostasis alteration and they respond accordingly, combining a defensive service with neuroprotective functions (Verkhratsky and Butt, 2013).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Verkhratsky and Butt, 2013
Not checked in the free run.
May combine two claims.
PremisecitationThe change of microglia between M1 and M2 phenotypes is a dynamic process and microglial activation can switch from M2 to M1 phenotype during the course of disease.
“The change of microglia between M1 and M2 phenotypes is a dynamic process and microglial activation can switch from M2 to M1 phenotype during the course of disease (Cherry et al., 2014).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Cherry et al., 2014 source
Not checked in the free run.
May combine two claims.
PremisecitationThe morphology of activated microglia includes retraction of processes, enlargement of the soma, and increased expression of myeloid cell markers.
“The morphology of activated microglia includes a retraction of processes, enlargement of the soma, and increased expression of myeloid cell markers (Ransohoff and Cardona, 2010).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ransohoff and Cardona, 2010 source
Not checked in the free run.
May combine two claims.
PremisecitationAfter acute M1 activation, microglial cells can suffer an uncontrolled activation leading to a state of chronic inflammation; in this state, microglia release neurotoxic inflammatory factors (TNF-α, IL-1α, IL-1β, IL-6, NO, hydrogen peroxide, superoxide anion, chemokines, and glutamate), which lead to neuronal death.
“After this acute M1 activation, microglial cells can suffer an uncontrolled activation leading to a state of chronic inflammation. In this state, microglia release neurotoxic inflammatory factors (TNF-α, IL-1α, IL-1β, IL-6, NO, hydrogen peroxide, superoxide anion, chemokines, and glutamate), which lead to neuronal death (Block et al., 2007; Lull and Block, 2010; Burguillos et al., 2011; Kettenmann”
Quote in the paperSubstantial claim0 of 3 sources checkedMay combine two claims.
PremisecitationM1 microglial cells present amoeboid morphology as well as high phagocytic capacity and motility.
“M1 microglial cells present amoeboid morphology as well as high phagocytic capacity and motility (Varnum and Ikezu, 2012; Gonzalez et al., 2014; Jones and Bouvier, 2014).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Varnum and Ikezu, 2012
Not checked in the free run.
- cites Gonzalez et al., 2014 source
Not checked in the free run.
- cites Jones and Bouvier, 2014
Not checked in the free run.
May combine two claims.
Premisenone givenThe neuroinflammatory process occurs not only in the brain, but also in the retina, which is a projection of the CNS.
“The neuroinflammatory process occurs not only in the brain, but also in the retina, which is a projection of the CNS.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisenone givenEVs have a heterogeneous molecular composition, including receptors, integrins and cytokines, bioactive lipids, miRNA, mRNA, DNA, and organelles, being similar to their parental cells.
“EVs have a heterogeneous molecular composition, including receptors, integrins and cytokines, bioactive lipids, miRNA, mRNA, DNA, and organelles, being similar to their parental cells.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationM2 microglia are the major effector cells with the potential to dampen pro-inflammatory immune responses and promote the expression of repair genes.
“M2 microglia are the major effector cells with the potential to dampen pro-inflammatory immune responses and promote the expression of repair genes (Tang and Le, 2016).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Tang and Le, 2016 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationMicroglial cells are CNS resident immune cells which have sensor and effector functions as well as phagocytic capacity.
“Microglial cells are CNS resident immune cells which have sensor and effector functions as well as phagocytic capacity (Streit et al., 2005).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Streit et al., 2005 source
Not checked in the free run.
May combine two claims.
PremisecitationThe retina and brain are similar and respond similarly to disease.
“The retina and brain are associated over a range of neurological and neurovascular conditions of varying etiologies, because the retina and brain are similar, and respond similarly to disease.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenMicroglial cells may undergo two different kinds of activation in response to infections or injuries: M1-like and M2-like.
“Microglial cells may undergo two different kinds of activation in response to infections or injuries. The first is a neurotoxic phenotype called M1-like.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationAfter injury, microglia become activated and change morphology, proliferate, migrate to damage sites, modify expression of enzymes and receptors, and release inflammatory factors such as NO, TNF-α, and IL-6.
“After injury these cells become activated and in this state change their morphology, proliferate, migrate to the damage sites, modify the expression of enzymes and receptors, and release a variety of inflammatory factors, such as NO, tumor necrosis factor (TNF-α), interleukin (IL-6) among others (Magni et al., 2012).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Magni et al., 2012 source
Not checked in the free run.
May combine two claims.
PremisecitationM2 microglia can release anti-inflammatory cytokines including IL-4, IL-13, IL-10, TGF-β and neurotrophic factors such as IGF-1 to assist inflammation resolution and promote neuron survival.
“These cells can release anti-inflammatory cytokines including IL-4, IL-13, IL-10, TGF-β and neurotrophic factors, such as insulin-like growth factor 1 (IGF-1) to assist inflammation resolution and promote neuron survival (Suh et al., 2013; Tang and Le, 2016).”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
Premisenone givenNeuroinflammation is essential to protect CNS tissue, but uncontrolled and prolonged neuroinflammation is potentially harmful and can cause cellular damage.
“Neuroinflammation, the inflammation of central nervous system (CNS), is essential to protect the tissue. However, uncontrolled and prolonged neuroinflammation is potentially harmful and can cause cellular damage.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationFractalkine is released by neurons and its receptor is expressed by microglia, constituting a neuron-microglial signaling system.
“Fractalkine, involved in indirect neuroprotection, is released by neurons and the receptor is expressed by microglia, their interactions constituting a neuron-microglial signaling system (Ransohoff and El Khoury, 2015).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ransohoff and El Khoury, 2015 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationMicroglia express CD11b/c, D45low, and the chemokine fractalkine receptor (CX3CR1).
“Microglia express CD11b/c, D45low, and the chemokine fractalkine receptor (CX3CR1) (Dudvarski Stankovic et al., 2016).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Dudvarski Stankovic et al., 2016 source
Not checked in the free run.
May combine two claims.
InterpretationcitationMicroglial EVs represent a "liquid biopsy" of their parental cells, and could provide information on the functional phenotype (protective or damaging) of microglial cells over the course of neurodegeneration.
“The microglial EVs representing a “liquid biopsy” of their parental cells, and could provide information on the functional phenotype (protective or damaging) of microglial cells over the course of neurodegeneration (Nigro et al., 2016).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Nigro et al., 2016 source
Not checked in the free run.
May combine two claims.
Premisenone givenAfter injury, astrocytes produce cytokines and chemokines (CCL2, CXCL1, CXCL10, GM-CSF, and IL-6), which activate microglia and recruit peripheral immune cells to the CNS.
“After injury, astrocytes produce cytokines and chemokines (CCL2, CXCL1, CXCL10, GM-CSF, and IL-6), which activate microglia and recruit peripheral immune cells to the CNS.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMicroglia and astrocytes are the main innate immune effector cells in the CNS.
“Microglia and astrocytes are the main innate immune effector cells in the CNS (da Fonseca et al., 2014).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites da Fonseca et al., 2014 source
Not checked in the free run.
May combine two claims.
PremisecitationIn AD, PD, and glaucoma, death occurs in one or more populations of neurons (retinal ganglion cells in glaucoma, hippocampal and cortical neurons in AD, and nigrostriatal dopaminergic neurons in PD).
“death occurs in one or more populations of neurons (RGCs in glaucoma, hippocampal and cortical neurons in AD and nigrostriatal dopaminergic neurons in PD) (Mattson, 2000).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Mattson, 2000 source
Not checked in the free run.
May combine two claims.
PremisecitationIn their state of high activation, microglial cells acquire an amoeboid morphology and act like macrophages, engulfing debris.
“In their state of high activation, microglial cells acquire an amoeboid morphology and act like macrophages, engulfing debris (Brown and Neher, 2014).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Brown and Neher, 2014 source
Not checked in the free run.
May combine two claims.
InterpretationreasoningAll this could generate oxidative stress, which leads to neuronal death.
“All this could generate oxidative stress, which leads to neuronal death.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Premisenone givenMicroglia, together with endothelial cells, pericytes, and astrocytes, form the functional blood-brain barrier (BBB) that selectively separates the brain parenchyma from blood circulation.
“Microglia, together with endothelial cells, pericytes, and astrocytes, form the functional blood-brain barrier (BBB) that selectively separates the brain parenchyma from blood circulation.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationNLRP3 inflammasome assembly and activation regulates activation of caspase-1, which catalyzes cleavage and activation of proinflammatory cytokines of the IL-1β family, promoting secretion of biologically active cytokines; these cytokines could induce neuronal degeneration.
“Their assembly and activation regulates activation of caspase-1, which catalyzes the cleavage and activation of proinflammatory cytokines of the IL-1β family, promoting the secretion of these, now biologically active, cytokines. These cytokines could induce neuronal degeneration (Gold and El Khoury, 2015).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Gold and El Khoury, 2015 source
Not checked in the free run.
May combine two claims.
PremisecitationActivated microglia can induce dysfunction of the BBB, being correlated with disruption of the BBB in neurodegenerative diseases.
“The activated microglia can induce the dysfunction of the BBB, being correlated with the disruption of the BBB in the neurodegenerative diseases (Dudvarski Stankovic et al., 2016).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Dudvarski Stankovic et al., 2016 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThis pathway plays a critical role in the initiation and regulation of innate immune responses and adaptive immunity.
“This pathway plays a critical role in the initiation and regulation of innate immune responses and adaptive immunity (Yan et al., 2016).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Yan et al., 2016 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe amyloid hypothesis for AD postulates that initial deposition of Aβ triggers mechanisms that progressively lead to Tau pathology, synaptic dysfunction, inflammation, neuronal loss and finally dementia.
“This model postulates that the initial deposition of Aβ triggers mechanisms that progressively lead to Tau pathology, synaptic dysfunction, inflammation, neuronal loss and finally to dementia (De Strooper and Karran, 2016).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites De Strooper and Karran, 2016 source
Not checked in the free run.
May combine two claims.
PremisecitationFor phagocytosis to occur, the expression of specific receptors on the microglial surface is necessary; the principal receptors are TLRs, which have high affinity for pathogens, and TREM2, which recognizes apoptotic cellular substances.
“As mentioned above, for phagocytosis to occur the expression of specific receptors on the microglial surface is necessary. The principal receptors are the TLRs, which have high affinity for pathogens, and TREM2, which recognizes apoptotic cellular substances (Hsieh et al., 2009).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hsieh et al., 2009 source
Not checked in the free run.
May combine two claims.
PremisecitationThe complement participates in the physiological process termed synaptic pruning; synapses and axons have to be labeled by complement components C1q and C3 before being phagocytosed, which prompts their selective recognition by microglial cells.
“The complement also participates in the physiological process, termed synaptic pruning. The synapses and axons have to be labeled by complement components C1q and C3 before being phagocytosed, which prompts their selective recognition by microglial cells (Paolicelli et al., 2011; Linnartz et al., 2012; Schafer et al., 2012).”
Quote in the paperNot a substantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThis pathway constitutes a pattern-recognition system by which microglial cells respond to foreign antigens and inflammation in the CNS.
“This pathway constitutes a pattern-recognition system by which microglial cells respond to foreign antigens and inflammation in the CNS (Hanisch and Kettenmann, 2007).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hanisch and Kettenmann, 2007 source
Not checked in the free run.
May combine two claims.
PremisecitationRAGE is an important cell-surface receptor for Aβ in endothelial cells, neurons, and microglia, and increased expression in these cell types has been demonstrated in AD.
“The RAGE is an important cell-surface receptor for Aβ in the endothelial cells, neurons, and microglia, and increased expression in these cell types has been demonstrated in AD (Yan et al., 1996).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Yan et al., 1996 source
Not checked in the free run.
May combine two claims.
PremisecitationActivated microglia can induce A1 astrocytes by secreting IL-1α, TNF, and C1q, and this type of astrocyte contributes to the death of neurons in neurodegenerative disorders and could be analog to the M1-like phenotype microglia.
“Activated microglia can induce A1 astrocytes by secreting IL-1α, TNF, and C1q, and this type of astrocyte contribute to the death of neurons in the neurodegenerative disorders and could be analog to the M1-like phenotype microglia (Liddelow et al., 2017).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Liddelow et al., 2017 source
Not checked in the free run.
May combine two claims.
PremisecitationThis inflammation not only occurs in response to Aβ deposition, but is also capable of generating, via feedback mechanisms, more Aβ while weakening the mechanisms responsible for its elimination.
“This inflammation not only occurs in response to Aβ deposition, but is also capable of generating, via feedback mechanisms, more Aβ while weakening the mechanisms responsible for its elimination (Parpura et al., 2012).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Parpura et al., 2012 source
Not checked in the free run.
May combine two claims.
PremisecitationThe primary pathogenic process in AD is the accumulation of Aβ protein, which aggregates into extracellular amyloid plaques, the hallmark of this pathology.
“The primary pathogenic process in AD is the accumulation of Aβ protein. This protein aggregates into extracellular amyloid plaques, which are the hallmark of this pathology (Southam et al., 2016).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Southam et al., 2016 source
Not checked in the free run.
May combine two claims.
PremisecitationTREM2 is a critical regulator of microglia and macrophage phenotype and is involved in neurodegenerative diseases.
“This receptor is a critical regulator of microglia and macrophage phenotype and is involved in neurodegenerative diseases (Andreasson et al., 2016).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Andreasson et al., 2016 source
Not checked in the free run.
May combine two claims.
PremisecitationThe interaction of Aβ with RAGE causes oxidative stress in neurons, enhances inflammatory responses in microglia, and is involved in reversed transport of Aβ across the BBB in endothelial cells.
“The interaction of Aβ with RAGE causes oxidative stress in neurons, enhances inflammatory responses in microglia, and is involved in reversed transport of Aβ across the BBB in endothelial cells (Deane et al., 2012).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Deane et al., 2012 source
Not checked in the free run.
May combine two claims.
PremisecitationThe TREM2 pathway is induced in microglial cells by anti-inflammatory cytokines, is modulated by CD33, and is down-regulated by agonists of TLR2, 4, and 9, as well as by inflammatory stimuli such as lipopolysaccharides and RNA interference; overexpression of TREM2 promotes phagocytosis and reduces the pro-inflammatory response.
“This pathway, induced in the microglial cells by anti-inflammatory cytokines, is modulated by CD33 and is down-regulated by agonists of TLR2, 4, and 9, as well as by inflammatory stimuli such as lipopolysaccharides and RNA interference. An overexpression of TREM2 promotes phagocytosis and reduces the pro-inflammatory response (Han et al., 2017).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Han et al., 2017 source
Not checked in the free run.
May combine two claims.
PremisecitationThe signaling pathway TREM2 regulates apoptosis, the immune response, and phagocytic activity.
“The signaling pathway TREM2 regulates apoptosis, the immune response, and phagocytic activity.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisereasoningThese activated cells can release both pro- and anti-inflammatory mediators, leading to a state of chronic inflammation in the tissue.
“These activated cells can release both pro- and anti-inflammatory mediators, leading to a state of chronic inflammation in the tissue.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationAlthough microglia are the main agents responsible for phagocytosis of cell debris in the CNS, the complement system can play a primordial role in removing damaged and apoptotic cells.
“Although microglia are the main agents responsible for phagocytosis of cell debris in the CNS, the complement system can play a primordial role in removing damaged and apoptotic cells (Fakhoury, 2016).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Fakhoury, 2016 source
Not checked in the free run.
May combine two claims.
PremisecitationNLRP3 inflammasome activation reduces phagocytosis of Aβ by microglial cells, thus increasing Aβ depositions and contributing to the pathogenesis of AD.
“In addition, NLRP3 inflammasome activation reduces phagocytosis of Aβ by microglial cells, thus increasing the Aβ depositions and contributing to the pathogenesis of AD (Garlanda et al., 2013; Gold and El Khoury, 2015).”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationAfter acute inflammatory damage, brain glial cells respond to repair the tissue; if the stimulus persists, it produces an inflammatory chronic state that leads to neuronal dysfunction, injury, and loss.
“After acute inflammatory damage, the brain glial cells respond to repair the tissue. If the stimulus persists, it produces an inflammatory chronic state that leads to neuronal dysfunction, injury, and loss (Streit et al., 2004; Calsolaro and Edison, 2016).”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
Premisenone givenAfter damage, microglia transform into active phagocytes; they migrate to the damaged area, adopt an amoeboid morphology, release both pro- and anti-inflammatory molecules, and remove apoptotic cells and debris.
“After damage, microglia transform into active phagocytes. These cells migrate to the damaged area and adopt an amoeboid morphology, releasing both pro- and anti-inflammatory molecules. They also have the capacity to remove apoptotic cells and debris.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationMicroglial cells can activate the complement by local secretion of the complement component from both the classical and the alternative pathway and also express C3 and C5.
“Microglial cells can activate the complement by local secretion of the complement component from both the classical and the alternative pathway and also express C3 and C5 (Luo et al., 2011).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Luo et al., 2011
Not checked in the free run.
May combine two claims.
PremisecitationActivated microglia are capable of upregulating CD11c, MHC I, and MHC II to act as antigen-presenting cells, which activate T cells; this activation would in turn damage the nervous system.
“In addition, activated microglia are capable of upregulating CD11c, MHC I, and MHC II to act as antigen-presenting cells, which activate T cells. This activation would in turn damage the nervous system (Xu et al., 2016).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Xu et al., 2016
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAlthough the same JAK/STAT components are used, the gene expression in response to a specific cytokine depends on the cell type.
“Although the same JAK/STAT components are used, the gene expression in response to a specific cytokine, depending on the cell type (van Boxel-Dezaire et al., 2006).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites van Boxel-Dezaire et al., 2006 source
Not checked in the free run.
May combine two claims.
PremisecitationCytokines bind to receptors in the microglia and activate the JAK/STAT signaling pathway.
“Cytokines bind to receptors in the microglia and activate the JAK/STAT signaling pathway (Yan et al., 2016).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Yan et al., 2016 source
Not checked in the free run.
May combine two claims.
Premisenone givenMicroglial cells are important for the normal functioning of neurons in the CNS; they provide trophic support to neurons and regulate synapses.
“Microglial cells are important for the normal functioning of neurons in the CNS. They provide trophic support to neurons and regulate synapses.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationcitationBoth inflammation and reduced microglial phagocytic capacity in AD can contribute to the decline in synaptic plasticity observed in this pathology.
“Both inflammation and reduced microglial phagocytic capacity in AD can contribute to the decline in synaptic plasticity observed in this pathology (Ritzel et al., 2015; Udeochu et al., 2016).”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationSynapse loss in the hippocampus and association cortices is an early hallmark of AD and strongly correlates with cognitive impairment.
“The synapse loss in the hippocampus and association cortices is an early hallmark of AD and strongly correlates with cognitive impairment (Hong et al., 2016).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hong et al., 2016 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
InterpretationreasoningPresumably, microglial proliferation around plaques could serve as a line of defense to limit the deposition of amyloid.
“Presumably, microglial proliferation around plaques could serve as a line of defense to limit the deposition of amyloid.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationMitochondrial malfunction leads to reduced energy metabolism and induces neuroinflammation via NO and ROS production, ultimately entailing neurodegeneration.
“It has been suggested that mitochondrial malfunction leads to reduced energy metabolism and induces neuroinflammation via NO and ROS production, which ultimately entails neurodegeneration (Vivekanantham et al., 2015).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Vivekanantham et al., 2015 source
Not checked in the free run.
May combine two claims.
Interpretationnone givenDuring development, microglia are involved in synapse elimination and these mechanisms may be aberrantly reactivated in the aged brain, contributing to synapse loss in AD.
“During development, microglia are involved in synapse elimination and these mechanisms may be aberrantly reactivated in the aged brain, contributing to the synapse loss in AD.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationActivation of the fractalkine receptor (CX3CR1) in microglial cells increases synaptic strength; deficiency in this receptor results in reduced hippocampal synaptic plasticity.
“The activation of the fractalkine receptor (CX3CR1) in microglial cells, increases synaptic strength. However, deficiency in this receptor results in a reduced hippocampal synaptic plasticity (Rogers et al., 2011; Clark et al., 2015).”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationTREM2 inhibits pro-inflammatory cytokine production, facilitates phagocytosis and promotes cell survival; thus TREM2 dysfunction could induce loss of homeostasis in the tissue.
“TREM2 inhibits pro-inflammatory cytokine production, facilitates phagocytosis and promotes cell survival. Thus, TREM2 dysfunction could induce the loss of the homeostasis in the tissue (Painter et al., 2015).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Painter et al., 2015 source
Not checked in the free run.
May combine two claims.
PremisecitationIn AD patients, astrocytes in the entorhinal cortex accumulate Aβ, this accumulation being positively correlated with the extent of AD.
“In AD patients, astrocytes in the entorhinal cortex accumulate Aβ, this accumulation being positively correlated with the extent of AD (Nagele et al., 2003).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Nagele et al., 2003 source
Not checked in the free run.
May combine two claims.
PremisecitationIn rat PD models, deficiency of CX3CL1 or CX3CR1 and dysfunction of CD200-CD200R signaling increase microglial activation and degeneration of DA neurons.
“In rat PD models, both deficiency CX3CL1 or CX3CR1 as well as the dysfunction of CD200-CD200R signaling have been shown to increase microglial activation and the degeneration of DA neurons (Wang et al., 2011; Zhang et al., 2011).”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationAstrocytes can induce microglia to perform Aβ phagocytosis by regulating the release of apo E and the ATP-binding cassette (ABCA) protein; in vitro studies have demonstrated that microglial phagocytosis of Aβ is more effective in the presence of supernatants derived from astrocytes.
“Moreover, astrocytes can also induce microglia to perform Aβ phagocytosis by regulating the release of the apo E and the ATP-binding cassette (ABCA) protein. Studies in vitro have demonstrated that microglial phagocytosis of Aβ is more effective in the presence of supernatants derived from astrocytes (Terwel et al., 2011).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Terwel et al., 2011 source
Not checked in the free run.
May combine two claims.
PremisecitationThe release of BDNF by microglial cells induces synaptic pruning; depletion of this factor in microglia results in learning and memory impairment.
“The release of brain-derived neurotrophic factor (BDNF) by microglial cells induces synaptic pruning. However, the depletion of this factor in the microglia results in learning and memory impairment (Parkhurst et al., 2013).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Parkhurst et al., 2013 source
Not checked in the free run.
May combine two claims.
PremisecitationActivated microglia can shed MVs in response to several signals, including cytokines; these MVs contain bioactive molecules (IL-1β, proteases, and MHC-II) which modulate the activity of neuronal and non-neuronal cells.
“Activated microglia can shed MVs in response to several signals, including cytokines. These MVs contain bioactive molecules (i.e., IL-1β, proteases, and MHC-II) which modulate the activity of neuronal and non-neuronal cells (Antonucci et al., 2012).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Antonucci et al., 2012 source
Not checked in the free run.
May combine two claims.
PremisecitationMicroglial-specific genetic alterations may be related to microglial dysfunction; expression of beclin 1 is reduced in the brain of patients with AD, leading to disruption in phagocytosis and retromer-mediated recycling of the phagocytic receptors CD36 and TREM2 in microglia.
“In addition, microglial-specific genetic alterations may be related to this microglial dysfunction. The expression of beclin 1, a protein associated with autophagy pathway, is reduced in the brain of patients with AD, leading to disruption in phagocytosis and retromer-mediated recycling of the phagocytic receptors CD36 and TREM2 in microglia (Mosher and Wyss-Coray, 2014).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Mosher and Wyss-Coray, 2014 source
Not checked in the free run.
May combine two claims.
PremisecitationAged microglia show reduced phagocytic capacity, which could be due partly to a reduction in the ability of microglia to recognize phagocytic targets.
“In addition, aged microglia show reduced phagocytic capacity. This process could be due partly to a reduction in the ability of microglia to recognize phagocytic targets (Udeochu et al., 2016).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Udeochu et al., 2016 source
Not checked in the free run.
May combine two claims.
PremisecitationIn AD brains, reactive microglia have been found colocalized with amyloid plaques; reactive astrocytes accumulate around senile plaques next to activated microglia.
“In AD brains reactive microglia has been found colocalized with amyloid plaques. In addition, the reactive astrocytes accumulate around senile plaques next to the activated microglia (Heneka et al., 2015).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Heneka et al., 2015 source
Not checked in the free run.
May combine two claims.
PremisecitationIn the healthy adult brain, complement components are downregulated; however, in aging brains, C1q and C3 are highly upregulated and deposited on synapses, particularly in the hippocampus, the most vulnerable region in synapse loss in AD.
“In the healthy adult brain, these complement components are downregulated. However, in aging brains, C1q and C3 are highly upregulated and are deposited on synapses, particularly in the hippocampus, the most vulnerable region in the synapse loss in AD (Bialas and Stevens, 2013).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Bialas and Stevens, 2013 source
Not checked in the free run.
May combine two claims.
PremisecitationpTau is observed from OPL to GCL in the retina of AD patients, and from ONL to GCL in transgenic mouse.
“In addition to Aβ plaques, pTau was observed from OPL to GCL in the retina of AD patients. Also, pTau has been found from the ONL to GCL in the transgenic mouse (Liu et al., 2009).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Liu et al., 2009 source
Not checked in the free run.
May combine two claims.
PremisecitationAβ deposition in AD retina is observed from ONL to NFL, more abundant in superior region where greater neuronal degeneration is detected.
“Aβ deposition was observed from the outer nuclear layer (ONL) to nerve fiber layer (NFL), being more abundant in the superior region of the retina where greater neuronal degeneration has been detected (Hardy and Selkoe, 2002; Selkoe, 2004, 2008; Alexandrov et al., 2011; Ratnayaka et al., 2015; Hart et al., 2016; Table 1).”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
PremisecitationAβ42 presents higher cellular toxicity, more aggregation capacity, and a more direct relation with AD pathology.
“This alloform presents higher cellular toxicity, more aggregation capacity, and a more direct relation with AD pathology (Qiu et al., 2015).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Qiu et al., 2015 source
Not checked in the free run.
May combine two claims.
PremisecitationAD is associated with reduction in number of optic nerve head axons and decrease in thickness of peripapillary and macular RNFL.
“Among them, there is a reduction in the number of optic nerve head axons and a decrease in the thickness of the peripapillary and macular retinal nerve fiber layer (RNFL) (Tsai et al., 1991; Hedges et al., 1996; Danesh-Meyer et al., 2006; Iseri et al., 2006; Paquet et al., 2007; Garcia-Martin et al., 2014; Salobrar-Garcia et al., 2015; Salobrar-García et al., 2016c) (Table 1).”
Quote in the paperNot a substantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationNeuroinflammation is produced by integrated responses of all CNS immune cells including microglia, astrocytes, and infiltrating T-lymphocytes.
“Neuroinflammation is produced by the set of integrated responses of all the CNS immune cells including microglia, astrocytes and infiltrating T-lymphocytes (Le et al., 2016).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Le et al., 2016
Not checked in the free run.
May combine two claims.
PremisecitationQuinolinic acid released by microglia can activate NMDA receptor signaling, leading to excitotoxicity and increased inflammatory response.
“By contrast, quinolinic acid, released by microglia, can activate the NMDA receptor-signaling pathway, leading to excitotoxicity and increasing the inflammatory response.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Lim C. K. et al., 2017 source
Not checked in the free run.
May combine two claims.
PremisecitationIn PD patients, pKr-2 expression is significantly increased and co-localized in activated microglia in the substantia nigra, leading to disruption of nigrostriatal DA projection.
“In addition, in PD patient's pKr-2 expression is significantly increased and co-localized in activated microglial in the substantia nigra, leading to disruption of the nigrostriatal DA projection.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Leem et al., 2016 source
Not checked in the free run.
May combine two claims.
PremisecitationHigh cytosolic concentrations of free DA can produce oxidative stress and interact with α-syn, promoting neurodegeneration.
“The high cytosolic concentrations of free DA can produce oxidative stress and can interact with α-syn, promoting the neurodegenerative process (Mosharov et al., 2006).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Mosharov et al., 2006 source
Not checked in the free run.
May combine two claims.
PremisecitationGliosis in PD is atypical: astrogliosis is largely absent while microglia is highly activated.
“Gliosis in the PD is an atypical activation where astrogliosis is largely absent while the microglia is highly activated by the disease.”
Quote in the paperSubstantial claim0 of 3 sources checkedMay combine two claims.
PremisecitationSerum populations of T-cell repertoires and interleukin-2 receptors are altered in glaucoma patients.
“Moreover, serum alteration of the populations of T-cell repertoires and of interleukin-2 receptors has been detected (Yang et al., 2001a).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Yang et al., 2001a
Not checked in the free run.
May combine two claims.
PremisecitationCFH functions as a cofactor in inactivation of C3b in alternative complement pathway, and low CFH levels result in complement activation, triggering inflammation in retina and brain.
“CFH functions as a cofactor in the inactivation of C3b in the alternative complement pathway, and thus low CFH levels result in complement activation, triggering inflammation in the retina and brain (Alexandrov et al., 2011).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Alexandrov et al., 2011 source
Not checked in the free run.
Probably not a substantial claim: may not pass S2 (checkable).
InterpretationreasoningFollow-up of neuroinflammatory processes in the retinal tissue may be useful for the early diagnosis and monitoring of neurodegenerative diseases.
“The follow up of neuroinflammatory processes in the retinal tissue may be useful for the early diagnosis and monitoring of neurodegenerative diseases.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Interpretationnone givenDifferential activation of microglia (M1 or M2 phenotypes) can produce a neurotoxic or neuroprotective environment.
“The differential activation of microglia (M1 or M2 phenotypes) can produce a neurotoxic or neuroprotective environment, and could constitute a key in neuroinflammation regulation.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone givenIn the regulation of microglial activation, several cell types including neurons, astrocytes, and T-cells are involved.
“In the regulation of microglial activation, several cell types including, neurons, astrocytes, and T-cells are involved.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationPD is a motor disorder associated with degeneration of dopaminergic neurons in the substantia nigra.
“As mentioned above, PD is a motor disorder associated with degeneration of dopaminergic neurons in the substantia nigra (Inzelberg et al., 2004).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Inzelberg et al., 2004 source
Not checked in the free run.
Probably not a substantial claim: may not pass S2 (checkable), S4 (based).
InterpretationreasoningIn the search for a new strategy to control neuroinflammation, changing the M1 phenotype to the M2 phenotype might be more effective than blocking microglial activation completely.
“In the search for a new strategy to control neuroinflammation, it might be more effective to change the M1 phenotype to the M2 phenotype than to block microglial activation completely.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationAbnormalities in visual function are reported in PD patients and correlated with changes in retinal tissue.
“Moreover, abnormalities in visual function have been reported (Bodis-Wollner, 1990; Nowacka et al., 2014) in PD patients and correlated with changes in retinal tissue (La Morgia et al., 2013; Yu et al., 2014) (Table 1).”
Quote in the paperNot a substantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone givenWhen the neuroinflammatory process is triggered by protein aggregates (Aß, α-syn, pTau etc.), peripheral immune cells infiltrate the CNS and prompt more activation of resident microglia, favoring neuroinflammatory processes.
“When the neuroinflammatory process is triggered by protein aggregates (Aß, α-syn, pTau etc.), peripheral immune cells infiltrate CNS and prompt more activation on resident microglia, favoring neuroinflammatory processes.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
LRRK2 is the most commonly mutated gene in both idiopathic and familial PD.
“LRRK2 is the most commonly mutated gene in both idiopathic and familial PD.”
The paper relies on this without support.
Persistent microglial activation exerts harmful effects that result in dopaminergic neuron death.
“Persistent microglial activation is known to exert harmful effects that result in dopaminergic neuron death.”
The paper relies on this without support.
Dopaminergic neurons are especially sensitive to factors that can induce cell damage and eventually cell death.
“In addition, dopaminergic neurons seem to be especially sensitive to several factors that can induce cell damage and eventually cell death.”
The paper relies on this without support.
Astrocytes secrete glutathione and transport it to neurons in response to neural excitatory stimuli.
“Astrocytes are responsible for secreting glutathione and transporting to neurons in response to neural excitatory stimuli.”
The paper relies on this without support.
α-syn aggregates are related to neurodegenerative disorders, including PD.
“However, α-syn aggregates are related to neurodegenerative disorders, including PD.”
The paper relies on this without support.
Under physiological conditions, some microglial cells express very low levels of MHC-II, although pro-inflammatory cytokines can upregulate MHC-II expression by microglial cells.
“Under physiological conditions, some microglial cells express very low levels of MHC-II, although certain pro-inflammatory cytokines (e.g., TNF-α or IFN-γ) can upregulate MHC-II expression by microglial cells.”
The paper relies on this without support.
For retinal homeostasis, the level of complement proteins should be low.
“For retinal homeostasis, the level of complement proteins should be low.”
The paper relies on this without support.
The retina is a projection of the CNS.
“because the retina is a projection of the CNS.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In early AD, microglia migrate to Aβ plaques.
“In the early stage of AD, microglia migrate to Aβ plagues,45, 46”
From Acoustofluidic assembly of 3D neurospheroids to model Alzheimer's disease (2020) · cites this paper as [46]
The “AD and microglia” section (page unavailable) says Aβ deposits can attract microglia and that microglia are found around amyloid plaques, supporting movement toward plaques. It does not establish that this occurs specifically in the early stage of AD; its discussion of early retinal activation is not a finding of migration to plaques. (LLM, conf=0.84)
Experimental — accuracy not yet measuredMicroglia form a protective barrier to protect brain tissue from the neurotoxicity of Aβ plaques.
“forming a protective barrier to protect brain tissue from the neurotoxicity of Aβ plaques”
From Acoustofluidic assembly of 3D neurospheroids to model Alzheimer's disease (2020) · cites this paper as [46]
The ‘AD and microglia’ section says microglia proliferating around plaques could serve as a line of defense by limiting amyloid deposition. It presents this as a possibility, however, and adds that microglia clustered around deposits may be unable to remove amyloid; it does not establish that they form a protective barrier against plaque neurotoxicity. (LLM, conf=0.87)
Experimental — accuracy not yet measuredDysregulated overactive microglia may contribute to prolonged inflammation and chronic disease progression.
“Although microglia are also neuroprotective under physiological conditions (Ramirez et al., 2017), it has been proposed that dysregulated overactive microglia, those clearing oxysterol debris by way of example, may contribute to the prolonged inflammation and chronic disease progression (Gao and Hong, 2008).”
From Microtubule-associated protein 1 light chain 3B, (LC3B) is necessary to maintain lipid-mediated homeostasis in the retinal pigment epithelium (2018) · cites this paper as Ramirez et al., 2017
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rotenone retinal model described as mice but cited study describes rats
MinorThe text calls the rotenone-treated animals mice, but the title of the cited study identifies the retinal model as rats.
“Also in the retina of mice treated with rotenone (pesticide that elicits DA neuron degenerations), an experimental model of PD, a correlation between functional and structural alterations were located in the retina, specifically in the photoreceptors and their synaptic connections with second-order neurons (Esteve-Rudd et al., 2011).”
“Esteve-Rudd J. Fernandez-Sanchez L. Lax P. De Juan E. Martin-Nieto J. Cuenca N. (2011). Rotenone induces degeneration of photoreceptors and impairs the dopaminergic system in the rat retina.”
Cites
1 retracted
Bialas, A. R., & Stevens, B. (2013) · Nature Neuroscience · doi:10.1038/nn.3560 · Cited by 519 · see citing works
RetractedThe Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864 · see citing works
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · see citing works
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359 · see citing works
Polazzi, E., Mengoni, I., Caprini, M., Peña‐Altamira, E., Kurtys, E., & Monti, B. (2012) · Neurosignals · doi:10.1159/000337115 · Cited by 9,023 · see citing works
Neurotoxic reactive astrocytes are induced by activated microglia
Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., Bennett, M. L., Münch, A. E., Chung, W.-S., Peterson, T. C., et al. (2017) · Nature · doi:10.1038/nature21029 · Cited by 7,971 · see citing works
The number of people with glaucoma worldwide in 2010 and 2020
Quigley, H. A. (2006) · British Journal of Ophthalmology · doi:10.1136/bjo.2005.081224 · Cited by 7,417 · see citing works
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226 · see citing works
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469 · see citing works
Astrocytes: Biology and pathology
Sofroniew, M. V., & Vinters, H. V. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0619-8 · Cited by 5,196 · see citing works
Microglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396 · see citing works
Synaptic Pruning by Microglia Is Necessary for Normal Brain Development
Paolicelli, R. C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., Giustetto, M., Ferreira, T. A., Guiducci, E., Dumas, L., et al. (2011) · Science · doi:10.1126/science.1202529 · Cited by 4,244 · see citing works
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210 · see citing works
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126 · see citing works
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
Block, M. L., Zecca, L., & Hong, J.-S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2038 · Cited by 4,110 · see citing works
Epidemiology of Parkinson's disease
de Lau, L. M., & Breteler, M. M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70471-9 · Cited by 4,110 · see citing works
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089 · cited 2× · see citing works
“The synapses and axons have to be labeled by complement components C1q and C3 before being phagocytosed, which prompts their selective recognition by microglial cells (Paolicelli et al., 2011; Linnartz et al., 2012; Schafer et al., 2012).”
BackgroundMicroglia: Active sensor and versatile effector cells in the normal and pathologic brain
Hanisch, U.-K., & Kettenmann, H. (2007) · Nature Neuroscience · doi:10.1038/nn1997 · Cited by 3,676 · see citing works
Mechanisms underlying inflammation in neurodegeneration
Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., & Gage, F. H. (2010) · Cell · doi:10.1016/j.cell.2010.02.016 · Cited by 3,580 · see citing works
Kettenmann, H., Hanisch, U.-K., Noda, M., & Verkhratsky, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00011.2010 · Cited by 3,547 · see citing works
Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1202-06.2006 · Cited by 3,530 · cited 3× · see citing works
“2000; Lukiw et al., 2001; Hardy and Selkoe, 2002; Oddo et al., 2003; Selkoe, 2004, 2008; Kumar-Singh et al., 2005; Oakley et al., 2006; Philipson et al., 2010; Alexandrov et al., 2011; Koronyo-Hamaoui et al., 2011; Kayabasi et al., 2014; Qiu et al., 2015; Ratnayaka et al., 2015; Hart et al.,…”
BackgroundUttara, B., Singh, A., Zamboni, P., & Mahajan, R. (2009) · Current Neuropharmacology · doi:10.2174/157015909787602823 · Cited by 3,378 · see citing works
NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
Heneka, M. T., Kummer, M. P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T.-C., et al. (2013) · Nature · doi:10.1038/nature11729 · Cited by 2,898 · see citing works
Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor
Parkhurst, C. N., Yang, G., Ninan, I., Savas, J. N., Yates, J. R., Lafaille, J. J., Hempstead, B. L., Littman, D. R., & Gan, W.-B. (2013) · Cell · doi:10.1016/j.cell.2013.11.030 · Cited by 2,599 · see citing works
Variant of <i>TREM2</i> Associated with the Risk of Alzheimer's Disease
Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A. I., Lah, J. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211103 · Cited by 2,558 · see citing works
Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases
Tang, Y., & Le, W. (2016) · Molecular Neurobiology · doi:10.1007/s12035-014-9070-5 · Cited by 2,190 · see citing works
RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., et al. (1996) · Nature · doi:10.1038/382685a0 · Cited by 2,012 · see citing works
The Cellular Phase of Alzheimer’s Disease
De Strooper, B., & Karran, E. (2016) · Cell · doi:10.1016/j.cell.2015.12.056 · Cited by 1,990 · see citing works
The interleukin-1 family: back to the future
Garlanda, C., Dinarello, C. A., & Mantovani, A. (2013) · Immunity · doi:10.1016/j.immuni.2013.11.010 · Cited by 1,945 · cited 1× · see citing works
“In addition, NLRP3 inflammasome activation reduces phagocytosis of Aβ by microglial cells, thus increasing the Aβ depositions and contributing to the pathogenesis of AD (Garlanda et al., 2013; Gold and El Khoury, 2015).”
BackgroundNeuroinflammation and M2 Microglia: The Good, the Bad, and the Inflamed
Cherry, J. D., Olschowka, J. A., & O’Banion, M. K. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-98 · Cited by 1,748 · see citing works
Neuroinflammation in Alzheimer's disease: current evidence and future directions
Calsolaro, V., & Edison, P. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.02.010 · Cited by 1,726 · see citing works
Apoptosis in neurodegenerative disorders
Mattson, M. P. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35040009 · Cited by 1,605 · see citing works
Giasson, B. I., Duda, J. E., Murray, I. V. J., Chen, Q., Souza, J. M., Hurtig, H. I., Ischiropoulos, H., Trojanowski, J. Q., & Lee, V. M. ‐. (2000) · Science · doi:10.1126/science.290.5493.985 · Cited by 1,551 · see citing works
Stewart, C. R., Stuart, L. M., Wilkinson, K., van Gils, J. M., Deng, J., Halle, A., Rayner, K. J., Boyer, L., Zhong, R., Frazier, W. A., et al. (2010) · Nature Immunology · doi:10.1038/ni.1836 · Cited by 1,513 · see citing works
Conway, K. A., Harper, J. D., & Lansbury, P. T. (1998) · Nature Medicine · doi:10.1038/3311 · Cited by 1,501 · see citing works
Anderson, J. P., Walker, D., Goldstein, J. M., de Laat, R., Banducci, K., Caccavello, R. J., Barbour, R., Huang, J., Kling, K., Lee, M., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600933200 · Cited by 1,418 · see citing works
ETIOLOGY AND PATHOGENESIS OF PARKINSON'S DISEASE
Olanow, C. W., & Tatton, W. G. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.123 · Cited by 1,394 · see citing works
Holcomb, L., Gordon, M. N., McGowan, E., Yu, X., Benkovic, S., Jantzen, P., Wright, K., Saad, I., Mueller, R., Morgan, D., et al. (1998) · Nature Medicine · doi:10.1038/nm0198-097 · Cited by 1,386 · see citing works
MACROPHAGE RECEPTORS AND IMMUNE RECOGNITION
Taylor, P. R., Martínez‐Pomares, L., Stacey, M. A., Lin, H.-H., Brown, G. D., & Gordon, S. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115816 · Cited by 1,325 · see citing works
Astrocytes are active players in cerebral innate immunity
Farina, C., Aloisi, F., & Meinl, E. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.01.005 · Cited by 1,304 · see citing works
Wyss-Coray (2006) · doi:10.1038/nm1484 · Cited by 1,284 · see citing works
Simard, A. R., Soulet, D., Gowing, G., Julien, J.-P., & Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.022 · Cited by 1,265 · see citing works
Streit, W. J., Walter, S. A., & Pennell, N. A. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00069-0 · Cited by 1,096 · see citing works
In-vivo measurement of activated microglia in dementia
Cagnin, A., Brooks, D. J., Kennedy, A. M., Gunn, R. N., Myers, R., Turkheimer, F. E., Jones, T., & Banati, R. B. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05625-2 · Cited by 1,054 · see citing works
Microglial Activation and Chronic Neurodegeneration
Lull, M. E., & Block, M. L. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.05.014 · Cited by 1,047 · see citing works
Microglia and neuroinflammation: a pathological perspective
Streit (2004) · Journal of Neuroinflammation · doi:10.1186/1742-2094-1-14 · Cited by 1,039 · see citing works
Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior
Selkoe, D. J. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.02.016 · Cited by 1,038 · see citing works
Sheedy, F. J., Grebe, A., Rayner, K. J., Kalantari, P., Ramkhelawon, B., Carpenter, S. B., Becker, C. E., Ediriweera, H. N., Mullick, A. E., Golenbock, D. T., et al. (2013) · Nature Immunology · doi:10.1038/ni.2639 · Cited by 935 · see citing works
Neuroinflammation in Parkinson's disease and its potential as therapeutic target
Wang, Q., Liu, Y., & Zhou, J. (2015) · Translational Neurodegeneration · doi:10.1186/s40035-015-0042-0 · Cited by 884 · see citing works
Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases
Selkoe, D. J. (2004) · Nature Cell Biology · doi:10.1038/ncb1104-1054 · Cited by 863 · see citing works
Microglial Phagocytosis of Live Neurons
Brown, G. C., & Neher, J. J. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3710 · Cited by 853 · see citing works
The myeloid cells of the central nervous system parenchyma
Ransohoff, R. M., & Cardona, A. E. (2010) · Nature · doi:10.1038/nature09615 · Cited by 804 · see citing works
UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis
Koizumi, S., Shigemoto-Mogami, Y., Nasu-Tada, K., Shinozaki, Y., Ohsawa, K., Tsuda, M., Joshi, B. V., Jacobson, K. A., Kohsaka, S., & Inoue, K. (2007) · Nature · doi:10.1038/nature05704 · Cited by 802 · see citing works
Hamza, T. H., Zabetian, C. P., Tenesa, A., Laederach, A., Montimurro, J. S., Yearout, D., Kay, D. M., Doheny, K. F., Paschall, J. E., Pugh, E., et al. (2010) · Nature Genetics · doi:10.1038/ng.642 · Cited by 779 · see citing works
TLR signaling tailors innate immune responses in human microglia and astrocytes
Jack, C. S., Arbour, N., Manusow, J., Montgrain, V., Blain, M., McCrea, E., Shapiro, A., & Antel, J. P. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.7.4320 · Cited by 734 · cited 1× · see citing works
“Concretely, TLR4 and TLR2 are associated with both neuro-inflammation and clearance of protein aggregates in neurodegenerative disorders (Jack et al., 2005).”
BackgroundMicroglia: biology and pathology
Graeber, M., & Streit, W. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0622-0 · Cited by 729 · see citing works
Toll‐like receptor 4 is required for α‐synuclein dependent activation of microglia and astroglia
Fellner, L., Irschick, R., Schanda, K., Reindl, M., Klimaschewski, L., Poewe, W., Wenning, G. K., & Stefanova, N. (2013) · Glia · doi:10.1002/glia.22437 · Cited by 697 · see citing works
Koronyo-Hamaoui, M., Koronyo, Y., Ljubimov, A. V., Miller, C. A., Ko, M. K., Black, K. L., Schwartz, M., & Farkas, D. L. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2010.06.020 · Cited by 672 · see citing works
Phagocytosis of Microglia in the Central Nervous System Diseases
Fu, R., Shen, Q., Xu, P., Luo, J. J., & Tang, Y. (2014) · Molecular Neurobiology · doi:10.1007/s12035-013-8620-6 · Cited by 646 · see citing works
CX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity
Rogers, J. T., Morganti, J. M., Bachstetter, A. D., Hudson, C. E., Peters, M. M., Grimmig, B. A., Weeber, E. J., Bickford, P. C., & Gemma, C. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3667-11.2011 · Cited by 624 · see citing works
Deane, R., Singh, I., Sagare, A. P., Bell, R. D., Ross, N. T., LaRue, B., Love, R., Perry, S., Paquette, N., Deane, R. J., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58642 · Cited by 619 · see citing works
Microglial dysfunction in brain aging and Alzheimer's disease
Mosher, K. I., & Wyss-Coray, T. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.01.008 · Cited by 618 · see citing works
Caspase signalling controls microglia activation and neurotoxicity
Burguillos, M. A., Deierborg, T., Kavanagh, E., Persson, A., Hajji, N., Garcia-Quintanilla, A., Cano, J., Brundin, P., Englund, E., Venero, J. L., et al. (2011) · Nature · doi:10.1038/nature09788 · Cited by 585 · see citing works
The impact of microglial activation on blood-brain barrier in brain diseases
da Fonseca, A. C. C., Matias, D., Garcia, C., Amaral, R., Geraldo, L. H., Freitas, C., & Lima, F. R. S. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00362 · Cited by 572 · see citing works
Chronic human glaucoma causing selectively greater loss of large optic nerve fibers
Quigley, H. A., Dunkelberger, G. R., & Green, W. R. (1988) · Ophthalmology · doi:10.1016/s0161-6420(88)33176-3 · Cited by 563 · see citing works
Glial cells in (patho)physiology
Parpura, V., Heneka, M. T., Montana, V., Oliet, S. H. R., Schousboe, A., Haydon, P. G., Stout, R. F., Spray, D. C., Reichenbach, A., Pannicke, T., et al. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07664.x · Cited by 561 · see citing works
Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease
Nelson, A. R., Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.12.016 · Cited by 559 · see citing works
New insights on the role of microglia in synaptic pruning in health and disease
Hong, S., Dissing-Olesen, L., & Stevens, B. (2016) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2015.12.004 · Cited by 557 · see citing works
Retinal microglia: Just bystander or target for therapy?
Karlstetter, M., Scholz, R., Rutar, M., Wong, W. T., Provis, J. M., & Langmann, T. (2014) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2014.11.004 · Cited by 550 · see citing works
Mogi, M., Harada, M., Narabayashi, H., Inagaki, H., Minami, M., & Nagatsu, T. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12706-3 · Cited by 545 · see citing works
Complex modulation of cell type-specific signaling in response to type I interferons
van Boxel-Dezaire, A. H. H., Rani, M. R. S., & Stark, G. R. (2006) · Immunity · doi:10.1016/j.immuni.2006.08.014 · Cited by 530 · see citing works
Microglia activation in retinal degeneration
Langmann, T. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0207114 · Cited by 496 · see citing works
Microglia Biology in Health and Disease
Garden, G. A., & Möller, T. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-006-9015-5 · Cited by 494 · see citing works
A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia
Hsieh, C. L., Koike, M., Spusta, S. C., Niemi, E. C., Yenari, M., Nakamura, M. C., & Seaman, W. E. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06042.x · Cited by 475 · see citing works
Cosenza‐Nashat, M., Zhao, M. ‐., Suh, H. ‐., Morgan, J., Natividad, R., Morgello, S., & Lee, S. C. (2009) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2008.01006.x · Cited by 459 · cited 1× · see citing works
“Thus, it has been proposed that neuroimaging of TSPO using PET is a good marker of neuroinflammation (Cosenza-Nashat et al., 2009; Pasqualetti et al., 2015).”
BackgroundNakazawa, T., Nakazawa, C., Matsubara, A., Noda, K., Hisatomi, T., She, H., Michaud, N. A., Hafezi‐Moghadam, A., Miller, J. W., & Benowitz, L. I. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.2801-06.2006 · Cited by 437 · see citing works
Gupta, N. (2006) · British Journal of Ophthalmology · doi:10.1136/bjo.2005.086769 · Cited by 434 · see citing works
Astrocytes accumulate Aβ42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains
Nagele, R. G., D’Andrea, M. R., Lee, H., Venkataraman, V., & Wang, H.-Y. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02361-8 · Cited by 416 · see citing works
Michelucci, A., Heurtaux, T., Grandbarbe, L., Morga, E., & Heuschling, P. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.02.003 · Cited by 411 · see citing works
Harms, A. S., Cao, S., Rowse, A. L., Thome, A. D., Li, X., Mangieri, L. R., Cron, R. Q., Shacka, J. J., Raman, C., & Standaert, D. G. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.5610-12.2013 · Cited by 406 · see citing works
Oxidative stress and mitochondrial dysfunction in glaucoma
Chrysostomou, V., Rezania, F., Trounce, I. A., & Crowston, J. G. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2012.09.008 · Cited by 403 · see citing works
Cuenca, N., Fernández-Sánchez, L., Campello, L., Maneu, V., De la Villa, P., Lax, P., & Pinilla, I. (2014) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2014.07.001 · Cited by 401 · see citing works
İşeri, P., Altıntaş, Ö., Tokay, T., & Yüksel, N. (2006) · Journal of Neuro-Ophthalmology · doi:10.1097/01.wno.0000204645.56873.26 · Cited by 400 · see citing works
TNF-alpha and TNF-alpha receptor-1 in the retina of normal and glaucomatous eyes.
Tezel, G., Li, L. Y., Patil, R. V., & Wax, M. B. (2001) · PubMed · Cited by 399 · see citing works
Varnum, M. M., & Ikezu, T. (2012) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-012-0181-2 · Cited by 393 · see citing works
Yücel, Y. (2003) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(03)00026-0 · Cited by 384 · see citing works
Neuroprotective role of the innate immune system by microglia
Glezer, I., Simard, A. R., & Rivest, S. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.02.055 · Cited by 371 · see citing works
Tofaris, G. K., Razzaq, A., Ghetti, B. F., Lilley, K. S., & Spillantini, M. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308041200 · Cited by 361 · see citing works
Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer's disease
Paquet, C., Boissonnot, M., Roger, F., Dighiero, P. L., Gil, R., & Hugon, J. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.02.090 · Cited by 353 · see citing works
González, H., Elgueta, D., Montoya, A., & Pacheco, R. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.07.012 · Cited by 352 · see citing works
Activated microglia in the human glaucomatous optic nerve head
Yuan, L., & Neufeld, A. H. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1104 · Cited by 348 · see citing works
Early microglia activation in a mouse model of chronic glaucoma
Bosco, A., Steele, M. R., & Vetter, M. L. (2010) · The Journal of Comparative Neurology · doi:10.1002/cne.22516 · Cited by 347 · see citing works
Retinal nerve fiber layer thinning in Parkinson disease
Inzelberg, R., Ramirez, J. A., Nisipeanu, P., & Ophir, A. (2004) · Vision Research · doi:10.1016/j.visres.2004.06.009 · Cited by 343 · cited 3× · see citing works
“…2007; Kesler et al., 2011; Garcia-Martin et al., 2014; Maldonado et al., 2015; Salobrar-Garcia et al., 2015, 2016a,b; Salobrar-García et al., 2016c Inzelberg et al., 2004; Yu et al., 2014; Stemplewitz et al., 2015; Boeke et al., 2016; Satue et al., 2017 Leung, 2016; Fallon et al., 2017 Inner…”
BackgroundNitric Oxide Synthase in the Human Glaucomatous Optic Nerve Head
Neufeld, A. H. (1997) · Archives of Ophthalmology · doi:10.1001/archopht.1997.01100150499009 · Cited by 342 · see citing works
Nitration of Tyrosine 10 Critically Enhances Amyloid β Aggregation and Plaque Formation
Kummer, M. P., Hermes, M., Delekarte, A., Hammerschmidt, T., Kumar, S., Terwel, D., Walter, J., Pape, H.-C., König, S., Roeber, S., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.07.001 · Cited by 336 · see citing works
Neuron–glia crosstalk in health and disease: fractalkine and CX 3 CR1 take centre stage
Sheridan, G. K., & Murphy, K. J. (2013) · Open Biology · doi:10.1098/rsob.130181 · Cited by 336 · see citing works
Microglia-Mediated Inflammation and Neurodegenerative Disease
Xu, L., Dan, H., & Bai, Y. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9593-4 · Cited by 332 · see citing works
Antonucci, F., Turola, E., Riganti, L., Caleo, M., Gabrielli, M., Perrotta, C., Novellino, L., Clementi, E., Giussani, P., Viani, P., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.489 · Cited by 328 · see citing works
The Role of Innate and Adaptive Immunity in Parkinson's Disease
Kannarkat, G. T., Boss, J. M., & Tansey, M. G. (2013) · Journal of Parkinson’s Disease · doi:10.3233/jpd-130250 · Cited by 324 · see citing works
Colony-stimulating factors as promoters of ameboid microglia
Giulian, D., & Ingeman, J. (1988) · Journal of Neuroscience · doi:10.1523/jneurosci.08-12-04707.1988 · Cited by 323 · see citing works
Hatfield, C. F. (2004) · Brain · doi:10.1093/brain/awh129 · Cited by 323 · see citing works
Bosco, A., Inman, D. M., Steele, M. R., Wu, G., Soto, I., Marsh‐Armstrong, N., Hubbard, W. C., Calkins, D. J., Horner, P. J., & Vetter, M. L. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-1337 · Cited by 322 · see citing works
Yan, Z., Gibson, S. A., Buckley, J. A., Qin, H., & Benveniste, E. N. (2018) · Clinical Immunology · doi:10.1016/j.clim.2016.09.014 · Cited by 318 · see citing works
Function of microglia and macrophages in secondary damage after spinal cord injury
Ren, Y., Zhou, X., & He, X. (2014) · Neural Regeneration Research · doi:10.4103/1673-5374.143423 · Cited by 317 · see citing works
An inflammatory review of Parkinson's disease
Orr, C. F., Rowe, D. B., & Halliday, G. M. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00127-2 · Cited by 309 · see citing works
Brown, G. C., & Vilalta, A. (2015) · Brain Research · doi:10.1016/j.brainres.2015.08.031 · Cited by 306 · see citing works
Schlamp, C. L., Li, Y., Dietz, J. A., Janssen, K. T., & Nickells, R. W. (2006) · BMC Neuroscience · doi:10.1186/1471-2202-7-66 · Cited by 303 · see citing works
Amyloid-β Deposits Lead to Retinal Degeneration in a Mouse Model of Alzheimer Disease
Ning, A., Cui, J., To, E., Ashe, K. H., & Matsubara, J. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-1849 · Cited by 303 · see citing works
Microglia in Health and Disease
Ransohoff, R. M., & Khoury, J. E. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a020560 · Cited by 303 · see citing works
Involvement of P2X 4 and P2Y 12 receptors in ATP‐induced microglial chemotaxis
Ohsawa, K., Irino, Y., Nakamura, Y., Akazawa, C., Inoue, K., & Kohsaka, S. (2007) · Glia · doi:10.1002/glia.20489 · Cited by 301 · see citing works
Microglia–blood vessel interactions: a double-edged sword in brain pathologies
Dudvarski Stankovic, N., Teodorczyk, M., Ploen, R., Zipp, F., & Schmidt, M. H. H. (2016) · Acta Neuropathologica · doi:10.1007/s00401-015-1524-y · Cited by 301 · see citing works
Retinal thickness in patients with mild cognitive impairment and Alzheimer's disease
Kesler, A., Vakhapova, V., Korczyn, A. D., Naftaliev, E., & Neudorfer, M. (2011) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2011.02.014 · Cited by 298 · see citing works
Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension.
McKinnon, S. J., Lehman, D. M., Kerrigan, L. A., Merges, C. A., Pease, M. E., Kerrigan, D., Ransom, N. L., Tahzib, N. G., Reitsamer, H. A., Levkovitch-Verbin, H., et al. (2002) · PubMed · Cited by 296 · see citing works
Bodis-Wollner, I. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90113-o · Cited by 296 · see citing works
Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease.
Yoram Vodovotz, B., Lucia, M. S., Flanders, K. C., Chesler, L., Xie, Q. W., Smith, T. W., Weidner, J. R., Mumford, R. A., Webber, R., Nathan, C., et al. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.4.1425 · Cited by 289 · see citing works
Neurobiology of retinal dopamine in relation to degenerative states of the tissue
Djamgoz, M. B. A., Hankins, M. W., Hirano, J., & Archer, S. N. (1997) · Vision Research · doi:10.1016/s0042-6989(97)00129-6 · Cited by 274 · see citing works
Inner Retinal Layer Thinning in Parkinson Disease
Hajee, M. E. (2009) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2009.106 · Cited by 269 · see citing works
Calabrese, V., Scapagnini, G., Giuffrida Stella, A. M., Bates, T. E., & Clark, J. B. (2001) · Neurochemical Research · doi:10.1023/a:1010955807739 · Cited by 263 · see citing works
Ocular indicators of Alzheimer’s: exploring disease in the retina
Hart, N. J., Koronyo, Y., Black, K. L., & Koronyo‐Hamaoui, M. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1613-6 · Cited by 260 · see citing works
Role of microglia in the central nervous system's immune response
Streit, W. J., Conde, J. R., Fendrick, S. E., Flanary, B. E., & Mariani, C. L. (2005) · Neurological Research · doi:10.1179/016164105x49463a · Cited by 258 · see citing works
Glial Physiology and Pathophysiology
Verkhratsky, A., & Butt, A. M. (2013) · Wiley eBooks · doi:10.1002/9781118402061 · Cited by 257 · see citing works
Appel, S. H., Beers, D. R., & Henkel, J. S. (2010) · Trends in Immunology · doi:10.1016/j.it.2009.09.003 · Cited by 256 · see citing works
Doorn, K. J., Moors, T., Drukarch, B., van de Berg, W. D., Lucassen, P. J., & van Dam, A.-M. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0090-1 · Cited by 254 · see citing works
Neuroinflammation in glaucoma: A new opportunity
Williams, P. A., Marsh-Armstrong, N., Howell, G. R., Bosco, A., Danias, J., Simon, J., Di Polo, A., Kuehn, M. H., Przedborski, S., Raff, M., et al. (2017) · Experimental Eye Research · doi:10.1016/j.exer.2017.02.014 · Cited by 253 · see citing works
Johnson, E. C., Jia, L., Cepurna, W. O., Doser, T. A., & Morrison, J. C. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-1282 · Cited by 249 · see citing works
Age-related macular degeneration (AMD): Alzheimer's disease in the eye?
Kaarniranta, K., Salminen, A., Haapasalo, A., Soininen, H., & Hiltunen, M. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-101908 · Cited by 248 · see citing works
Microglia in the Optic Nerve Head and the Region of Parapapillary Chorioretinal Atrophy in Glaucoma
Neufeld, A. H. (1999) · Archives of Ophthalmology · doi:10.1001/archopht.117.8.1050 · Cited by 248 · see citing works
Enhanced tau aggregation in the presence of Amyloid β
Bennett, R. E., DeVos, S. L., Dujardin, S., Corjuc, B., Gor, R., Gonzalez, J., Roe, A. D., Frosch, M. P., Pitstick, R., Carlson, G. A., et al. (2017) · The American Journal of Pathology · doi:10.1016/j.ajpath.2017.03.011 · Cited by 245 · see citing works
Microglia in the aging brain: relevance to neurodegeneration
Luo, X.-G., Ding, J.-Q., & Chen, S.-D. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-12 · Cited by 236 · cited 2× · see citing works
“…Farina et al., 2007; Inman and Horner, 2007; Johnson et al., 2007; Hammam et al., 2008; Tezel, 2009; Ebneter et al., 2010; Graeber and Streit, 2010; Luo et al., 2010; Bosco et al., 2011, 2012; Kettenmann et al., 2011; London et al., 2011; Bosco et al., 2012; Gallego et al., 2012; Varnum and…”
BackgroundHowell, G. R., Soto, I., Zhu, X., Ryan, M. M., Macalinao, D. G., Sousa, G. L., Caddle, L. B., MacNicoll, K. H., Barbay, J. M., Porciatti, V., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61135 · Cited by 233 · see citing works
Apoptosis of Retinal Ganglion Cells in Glaucoma
Nickells, R. W. (1999) · Survey of Ophthalmology · doi:10.1016/s0039-6257(99)00029-6 · Cited by 232 · see citing works
Perez, S. E., Lumayag, S., Kovacs, B., Mufson, E. J., & Xu, S. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2384 · Cited by 231 · see citing works
Glaucoma ocular Alzheimer s disease
McKinnon, S. J. (2003) · Frontiers in bioscience · doi:10.2741/1172 · Cited by 229 · see citing works
Takeuchi, A., Irizarry, M. C., Duff, K., Saido, T. C., Hsiao Ashe, K., Hasegawa, M., Mann, D. M. A., Hyman, B. T., & Iwatsubo, T. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64544-0 · Cited by 229 · see citing works
Contribution of Microglia‐Mediated Neuroinflammation to Retinal Degenerative Diseases
Madeira, M. H., Boia, R., Santos, P. F., Ambrósio, A. F., & Santiago, A. R. (2015) · Mediators of Inflammation · doi:10.1155/2015/673090 · Cited by 227 · see citing works
Suh, H.-S., Zhao, M.-L., Derico, L., Choi, N., & Lee, S. C. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-37 · Cited by 226 · see citing works
Gallego, B. I., Salazar, J. J., de Hoz, R., Rojas, B., Ramírez, A. I., Salinas-Navarro, M., Ortín-Martínez, A., Valiente-Soriano, F. J., Avilés-Trigueros, M., Villegas-Perez, M. P., et al. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-92 · Cited by 224 · see citing works
Self-citationAlzheimer’s disease as an inflammatory disease
Bolós, M., Perea, J. R., & Avila, J. (2017) · BioMolecular Concepts · doi:10.1515/bmc-2016-0029 · Cited by 216 · see citing works
London, A., Itskovich, E., Benhar, I., Kalchenko, V., Mack, M., Jung, S., & Schwartz, M. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20101202 · Cited by 213 · see citing works
The Eye As a Biomarker for Alzheimer's Disease
Lim, J. K. H., Li, Q.-X., He, Z., Vingrys, A. J., Wong, V. H. Y., Currier, N. V., Mullen, J., Bui, B. V., & Nguyen, C. T. O. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00536 · Cited by 211 · see citing works
Naskar, R., Wissing, M., & Thanos, S. (2002) · PubMed · Cited by 209 · see citing works
Zecca, L., Wilms, H., Geick, S., Claasen, J.-H., Brandenburg, L.-O., Holzknecht, C., Panizza, M. L., Zucca, F. A., Deuschl, G., Sievers, J., et al. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0361-7 · Cited by 205 · see citing works
Reactive nonproliferative gliosis predominates in a chronic mouse model of glaucoma
Inman, D. M., & Horner, P. J. (2007) · Glia · doi:10.1002/glia.20516 · Cited by 205 · see citing works
Complement Component 1Q (C1Q) Upregulation in Retina of Murine, Primate, and Human Glaucomatous Eyes
Stasi, K., Nagel, D., Yang, X., Wang, R., Ren, L., Podos, S. M., Mittag, T. W., & Danias, J. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-0830 · Cited by 201 · see citing works
Ebneter, A., Casson, R. J., Wood, J. P. M., & Chidlow, G. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-5284 · Cited by 198 · see citing works
Microglia in the healthy and degenerating retina: Insights from novel mouse models
Karlstetter, M., Ebert, S., & Langmann, T. (2010) · Immunobiology · doi:10.1016/j.imbio.2010.05.010 · Cited by 197 · see citing works
Retinal Nerve Fiber Layer Thickness Changes in Parkinson Disease: A Meta-Analysis
Yu, J.-G., Feng, Y.-F., Xiang, Y., Huang, J.-H., Savini, G., Parisi, V., Yang, W.-J., & Fu, X.-A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085718 · Cited by 197 · see citing works
Microarray analysis of retinal gene expression in the DBA/2J model of glaucoma
Steele, M. R., Inman, D. M., Calkins, D. J., Horner, P. J., & Vetter, M. L. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-0865 · Cited by 196 · see citing works
α‐synuclein in the inner retina in parkinson disease
Bodis‐Wollner, I., Kozlowski, P. B., Glazman, S., & Miri, S. (2014) · Annals of Neurology · doi:10.1002/ana.24182 · Cited by 192 · see citing works
β-amyloid, microglia, and the inflammasome in Alzheimer’s disease
Gold, M., & El Khoury, J. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0518-0 · Cited by 187 · see citing works
Retinal Macroglial Responses in Health and Disease
de Hoz, R., Rojas, B., Ramírez, A. I., Salazar, J. J., Gallego, B. I., Triviño, A., & Ramírez, J. M. (2016) · BioMed Research International · doi:10.1155/2016/2954721 · Cited by 187 · see citing works
Self-citationRojas, B., Gallego, B., Ramirez, A. I., Salazar, J. J., de Hoz, R., Valiente‐Soriano, F. J., Avilés‐Trigueros, M., Villegas‐Pérez, M. P., Vidal‐Sanz, M., Triviño, A., et al. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-133 · Cited by 186 · see citing works
Self-citationLiu, B., Rasool, S., Yang, Z., Glabe, C. G., Schreiber, S. S., Ge, J., & Tan, Z. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.090159 · Cited by 182 · see citing works
Terwel, D., Steffensen, K. R., Verghese, P. B., Kummer, M. P., Gustafsson, J.-Å., Holtzman, D. M., & Heneka, M. T. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.6546-10.2011 · Cited by 181 · see citing works
A <i>β</i> 42 and A <i>β</i> 40: similarities and differences
Qiu, T., Liu, Q., Chen, Y., Zhao, Y., & Li, Y. (2015) · Journal of Peptide Science · doi:10.1002/psc.2789 · Cited by 180 · see citing works
Kumar‐Singh, S., Pirici, D. N., McGowan, E. M., Serneels, S., Ceuterick, C., Hardy, J., Duff, K., Dickson, D. W., & Broeckhoven, C. V. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62995-1 · Cited by 179 · see citing works
Selective activation of microglia facilitates synaptic strength
Clark, A. K., Gruber-Schoffnegger, D., Drdla-Schutting, R., Gerhold, K. J., Malcangio, M., & Sandkühler, J. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2061-14.2015 · Cited by 171 · see citing works
Neuroinflammation in Parkinson's disease: role in neurodegeneration and tissue repair
Vivekanantham, S., Shah, S., Dewji, R., Dewji, A., Khatri, C., & Ologunde, R. (2015) · International Journal of Neuroscience · doi:10.3109/00207454.2014.982795 · Cited by 171 · see citing works
Astrocyte-Secreted Matricellular Proteins in CNS Remodelling during Development and Disease
Jones, E. V., & Bouvier, D. S. (2014) · Neural Plasticity · doi:10.1155/2014/321209 · Cited by 169 · see citing works
TREM2 in CNS homeostasis and neurodegenerative disease
Painter, M. M., Atagi, Y., Liu, C.-C., Rademakers, R., Xu, H., Fryer, J. D., & Bu, G. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0040-9 · Cited by 169 · see citing works
Mitochondrial dysfunction in glaucoma and emerging bioenergetic therapies
Lee, S., Bergen, N. J. V., Kong, G. Y. X., Chrysostomou, V., Waugh, H. S., O’Neill, E. C., Crowston, J. G., & Trounce, I. A. (2010) · Experimental Eye Research · doi:10.1016/j.exer.2010.07.015 · Cited by 166 · see citing works
α-Synuclein Overexpression Increases Cytosolic Catecholamine Concentration
Mosharov, E. V., Staal, R. G. W., Bové, J., Prou, D., Hananiya, A., Markov, D., Poulsen, N., Larsen, K. E., Moore, C. M. H., Troyer, M. D., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0519-06.2006 · Cited by 165 · see citing works
Reduction of optic nerve fibers in patients with Alzheimer disease identified by laser imaging
Danesh-Meyer, H. V., Birch, H., Ku, J. Y.-F., Carroll, S., & Gamble, G. (2006) · Neurology · doi:10.1212/01.wnl.0000244490.07925.8b · Cited by 164 · see citing works
The Role of Glia, Mitochondria, and the Immune System in Glaucoma
Tezel, G. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2717 · Cited by 164 · see citing works
Microglia, the first line of defence in brain pathologies.
Kreutzberg, G. W. (1995) · PubMed · Cited by 164 · see citing works
Optic nerve head and nerve fiber layer in Alzheimer's disease
Tsai, C. S. (1991) · Archives of Ophthalmology · doi:10.1001/archopht.1991.01080020045040 · Cited by 163 · see citing works
Involvement of the kynurenine pathway in the pathogenesis of Parkinson's disease
Lim, C. K., Fernández-Gomez, F. J., Braidy, N., Estrada, C., Costa, C., Costa, S., Bessede, A., Fernandez-Villalba, E., Zinger, A., Herrero, M. T., et al. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.12.009 · Cited by 159 · see citing works
Glia in the pathogenesis of neurodegenerative diseases
Verkhratsky, A., Parpura, V., Pekna, M., Pekny, M., & Sofroniew, M. V. (2014) · Biochemical Society Transactions · doi:10.1042/bst20140107 · Cited by 157 · see citing works
Wu, L., Vadakkan, K. I., & Zhuo, M. (2007) · Glia · doi:10.1002/glia.20500 · Cited by 156 · see citing works
Zhang, Q.-S., Heng, Y., Yuan, Y.-H., & Chen, N.-H. (2017) · Toxicology Letters · doi:10.1016/j.toxlet.2016.11.002 · Cited by 156 · see citing works
Zhang, S., Wang, X.-J., Tian, L.-P., Pan, J., Lu, G.-Q., Zhang, Y.-J., Ding, J.-Q., & Chen, S.-D. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-154 · Cited by 154 · see citing works
Dementia of the eye: the role of amyloid beta in retinal degeneration
Ratnayaka, J. A., Serpell, L. C., & Lotery, A. J. (2015) · Eye · doi:10.1038/eye.2015.100 · Cited by 153 · see citing works
Ocular changes in TgF344-AD rat model of Alzheimer's disease
Tsai, Y., Lu, B., Ljubimov, A. V., Girman, S., Ross-Cisneros, F. N., Sadun, A. A., Svendsen, C. N., Cohen, R. M., & Wang, S. (2014) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.13-12888 · Cited by 153 · see citing works
Evidence of Inflammatory System Involvement in Parkinson’s Disease
Chao, Y., Wong, S. C., & Tan, E. K. (2014) · BioMed Research International · doi:10.1155/2014/308654 · Cited by 150 · see citing works
Phosphorylated α-synuclein-immunoreactive retinal neuronal elements in Parkinson's disease subjects
Beach, T. G., Carew, J., Serrano, G. E., Adler, C. H., Shill, H. A., Sue, L. I., Sabbagh, M. N., Akiyama, H., & Cuenca, N. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.04.027 · Cited by 141 · see citing works
Oral Microbiome Link to Neurodegeneration in Glaucoma
Astafurov, K. V., Elhawy, E., Ren, L., Dong, C. Q., Igboin, C. O., Hyman, L., Griffen, A. L., Mittag, T. W., & Danias, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104416 · Cited by 140 · see citing works
Ding, Y. M., Jaumotte, J. D., Signore, A. P., & Zigmond, M. J. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02415.x · Cited by 137 · see citing works
Early axonopathy preceding neurofibrillary tangles in mutant tau transgenic mice
Leroy, K., Bretteville, A., Schindowski, K., Gilissen, E., Authelet, M., De Decker, R., Yilmaz, Z., Buée, L., & Brion, J.-P. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070345 · Cited by 135 · see citing works
Retinal tau pathology in human glaucomas
Gupta, N., Fong, J., Ang, L. C., & Yücel, Y. H. (2008) · Canadian Journal of Ophthalmology · doi:10.3129/i07-185 · Cited by 134 · see citing works
Age- and location-related changes in microglial function
Ritzel, R. M., Patel, A. R., Pan, S., Crapser, J., Hammond, M., Jellison, E., & McCullough, L. D. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.02.016 · Cited by 134 · see citing works
Clinical and Ocular Histopathological Findings in a Patient With Normal-Pressure Glaucoma
Wax, M. B. (1998) · Archives of Ophthalmology · doi:10.1001/archopht.116.8.993 · Cited by 134 · see citing works
Early Reduction of Microglia Activation by Irradiation in a Model of Chronic Glaucoma
Bosco, A., Crish, S. D., Steele, M. R., Romero, C. O., Inman, D. M., Horner, P. J., Calkins, D. J., & Vetter, M. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043602 · Cited by 134 · see citing works
Linnartz, B., Kopatz, J., Tenner, A. J., & Neumann, H. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.3830-11.2012 · Cited by 134 · see citing works
Gasparini, L., Anthony Crowther, R., Martin, K. R., Berg, N., Coleman, M., Goedert, M., & Spillantini, M. G. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.03.002 · Cited by 133 · see citing works
The Role of Neuroinflammation in Dementias
Pasqualetti, G., Brooks, D. J., & Edison, P. (2015) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-015-0531-7 · Cited by 133 · see citing works
The complex relationships between microglia, alpha-synuclein, and LRRK2 in Parkinson's disease
Schapansky, J., Nardozzi, J. D., & LaVoie, M. J. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2014.09.049 · Cited by 132 · see citing works
Gramlich, O. W., Gehrke-Beck, S., Hohenstein-Blaul, N. V. T. U., Boehm, N., Ziegler, A., Vetter, J. M., Pfeiffer, N., & Grus, F. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057557 · Cited by 132 · see citing works
Retinal amyloid peptides and complement factor H in transgenic models of Alzheimer's disease
Alexandrov, P. N., Pogue, A., Bhattacharjee, S., & Lukiw, W. J. (2011) · Neuroreport · doi:10.1097/wnr.0b013e3283497334 · Cited by 128 · see citing works
Krasodomska, K., Lubiński, W., Potemkowski, A., & Honczarenko, K. (2010) · Documenta Ophthalmologica · doi:10.1007/s10633-010-9238-x · Cited by 127 · see citing works
Targeting innate immunity for neurodegenerative disorders of the central nervous system
Andreasson, K. I., Bachstetter, A. D., Colonna, M., Ginhoux, F., Holmes, C., Lamb, B., Landreth, G., Lee, D. C., Low, D., Lynch, M. A., et al. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13667 · Cited by 126 · see citing works
Gupta, N., Ly, T., Zhang, Q., Kaufman, P. L., Weinreb, R. N., & Yücel, Y. H. (2007) · Experimental Eye Research · doi:10.1016/j.exer.2006.09.013 · Cited by 122 · see citing works
Immune regulation toward immunomodulation for neuroprotection in glaucoma
Tezel, G. (2012) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2012.09.013 · Cited by 120 · see citing works
Ophthalmological features of Parkinson disease
Safranow, K. (2014) · Medical Science Monitor · doi:10.12659/msm.890861 · Cited by 119 · cited 1× · see citing works
“Moreover, abnormalities in visual function have been reported (Bodis-Wollner, 1990; Nowacka et al., 2014) in PD patients and correlated with changes in retinal tissue (La Morgia et al., 2013; Yu et al., 2014) (Table 1).”
BackgroundCao, S., Standaert, D. G., & Harms, A. S. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-259 · Cited by 115 · see citing works
T cell subsets and sIL-2R/IL-2 levels in patients with glaucoma
Yang, J., Patil, R. V., Yu, H., Gordon, M. O., & Wax, M. B. (2001) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(00)00862-x · Cited by 114 · see citing works
Add Alzheimer's disease to the list of autoimmune diseases
D’Andrea, M. R. (2005) · Medical Hypotheses · doi:10.1016/j.mehy.2004.08.024 · Cited by 113 · see citing works
Serum autoantibodies to heat shock proteins in glaucoma patients from Japan and the United States
Wax, M. (2001) · Ophthalmology · doi:10.1016/s0161-6420(00)00525-x · Cited by 112 · see citing works
Protective Microglia and Their Regulation in Parkinson’s Disease
Le, W., Wu, J., & Tang, Y. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00089 · Cited by 112 · see citing works
Lauro, C., Di Angelantonio, S., Cipriani, R., Sobrero, F., Antonilli, L., Brusadin, V., Ragozzino, D., & Limatola, C. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7590 · Cited by 110 · see citing works
Loss of temporal retinal nerve fibers in Parkinson disease: a mitochondrial pattern?
La Morgia, C., Barboni, P., Rizzo, G., Carbonelli, M., Savini, G., Scaglione, C., Capellari, S., Bonazza, S., Giannoccaro, M. P., Calandra‐Buonaura, G., et al. (2013) · European Journal of Neurology · doi:10.1111/j.1468-1331.2012.03701.x · Cited by 110 · see citing works
Flagged first, then by citations
Research works printed but not linked: 5
- Garcia-Ospina, 2003, Neuronal DNA damage correlates with a positive detection of c-Jun, nuclear factor kB, p53 and Par-4 transcription factors in Alzheimer's disease, Rev. Neurol, 36, 1004
- Guimaraes, 2009, Mechanisms of secondary degeneration in the central nervous system during acute neural disorders and white matter damage, Rev. Neurol., 48, 304
- Martínez-Lazcano, 2010, Radicales libres y estrés oxidativo en las enfermedades neurodegenerativas, Mensaje Bioquim, 34, 43
- Park, 2013, Neurodegeneration in Glaucoma and Alzheimer's disease, 59
- Salobrar-García, cular manifestations of dementia: the eye and its role in the diagnosis and monitoring, Chapter 15
Cited by
Sorted by citations
Microglia Phenotypes in Aging and Neurodegenerative Diseases
Wendimu, M. Y., & Hooks, S. B. (2022) · Cells · doi:10.3390/cells11132091 · Cited by 336 · see citing works
Lee, K. S., Lin, S., Copland, D. A., Dick, A. D., & Liu, J. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02088-0 · Cited by 150 · see citing works
Acoustofluidic assembly of 3D neurospheroids to model Alzheimer's disease
Cai, H., Ao, Z., Hu, L., Moon, Y., Wu, Z., Lu, H.-C., Kim, J., & Guo, F. (2020) · The Analyst · doi:10.1039/d0an01373k · Cited by 70 · see citing works
Wong, K. A., & Benowitz, L. I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231710179 · Cited by 66 · see citing works
Retinal and brain microglia in multiple sclerosis and neurodegeneration
Choi, S., Guo, L., & Cordeiro, M. F. (2021) · Cells · doi:10.3390/cells10061507 · Cited by 63 · see citing works
The killifish visual system as an in vivo model to study brain aging and rejuvenation
Vanhunsel, S., Bergmans, S., Beckers, A., Etienne, I., Van houcke, J., Seuntjens, E., Arckens, L., De Groef, L., & Moons, L. (2021) · npj Aging and Mechanisms of Disease · doi:10.1038/s41514-021-00077-4 · Cited by 58 · see citing works
Probiotics and the Treatment of Parkinson's Disease: An Update
Mirzaei, H., Sedighi, S., Kouchaki, E., Barati, E., Dadgostar, E., Aschner, M., & Tamtaji, O. R. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01128-w · Cited by 57 · see citing works
Dhingra, A., Bell, B. A., Peachey, N. S., Daniele, L. L., Reyes-Reveles, J., Sharp, R. C., Jun, B., Bazan, N. G., Sparrow, J. R., Kim, H. J., et al. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00351 · Cited by 41 · see citing works
Evaluating the neuroprotective impact of senolytic drugs on human vision
El-Nimri, N. W., Moore, S. M., Zangwill, L. M., Proudfoot, J. A., Weinreb, R. N., Skowronska-Krawczyk, D., & Baxter, S. L. (2020) · Scientific Reports · doi:10.1038/s41598-020-78802-4 · Cited by 22 · see citing works
Non-invasive in vivo imaging of brain and retinal microglia in neurodegenerative diseases
Etebar, F., Harkin, D. G., White, A. R., & Dando, S. J. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1355557 · Cited by 7 · see citing works
- Authors
- Ramirez, A. I., de Hoz, R., Salobrar-Garcia, E., Salazar, J. J., Rojas, B., Ajoy, D., López-Cuenca, I., Rojas, P., Triviño, A., & Ramírez, J. M.
- Affiliations
- Universidad Complutense de Madrid (ES)
- Venue
- Frontiers in Aging Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2017-07-06
- Volume
- 9
- Pages
- 214-214
- ISSN
- 1663-4365 (ISSN-L)
- PMC
- PMC5498525
- OpenAlex
- W2728593064
- Semantic Scholar
- d19f3f3a860a90577db4955cf34ab6d6c58a68eb
- Cited by
- 466
- References
- 297
- Citations by year
- 2026: 25 · 2025: 41 · 2024: 50 · 2023: 51 · 2022: 66 · 2021: 78 · 2020: 59 · 2019: 47 · 2018: 38 · 2017: 11
- FWCI
- 4.09
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Frontiers in Aging Neuroscience (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Library Open Repository (Universidad Complutense Madrid) (submittedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Instituto de Salud Carlos III (RD16/0008/0005)
- Ministerio de Economía y Competitividad (SAF-2014-53779-R)
- Ministerio de Educación, Cultura y Deporte (FPU13/01910)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Keywords
- microglia, retinal neurodegeneration, neuroinflammation, Alzheimer's disease, Parkinson's disease, glaucoma, amyloid-beta, tau protein, alpha-synuclein, Lewy bodies, retinal ganglion cell death, dopaminergic neurons, optic nerve, inflammatory cytokines, microglial activation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-09.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-09.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review